Skip to main content
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology logoLink to American Journal of Physiology - Regulatory, Integrative and Comparative Physiology
. 2010 Oct 20;300(2):R222–R235. doi: 10.1152/ajpregu.00556.2010

Hindbrain noradrenergic A2 neurons: diverse roles in autonomic, endocrine, cognitive, and behavioral functions

Linda Rinaman 1,
PMCID: PMC3043801  PMID: 20962208

Abstract

Central noradrenergic (NA) signaling is broadly implicated in behavioral and physiological processes related to attention, arousal, motivation, learning and memory, and homeostasis. This review focuses on the A2 cell group of NA neurons, located within the hindbrain dorsal vagal complex (DVC). The intra-DVC location of A2 neurons supports their role in vagal sensory-motor reflex arcs and visceral motor outflow. A2 neurons also are reciprocally connected with multiple brain stem, hypothalamic, and limbic forebrain regions. The extra-DVC connections of A2 neurons provide a route through which emotional and cognitive events can modulate visceral motor outflow and also a route through which interoceptive feedback from the body can impact hypothalamic functions as well as emotional and cognitive processing. This review considers some of the hallmark anatomical and chemical features of A2 neurons, followed by presentation of evidence supporting a role for A2 neurons in modulating food intake, affective behavior, behavioral and physiological stress responses, emotional learning, and drug dependence. Increased knowledge about the organization and function of the A2 cell group and the neural circuits in which A2 neurons participate should contribute to a better understanding of how the brain orchestrates adaptive responses to the various threats and opportunities of life and should further reveal the central underpinnings of stress-related physiological and emotional dysregulation.

Keywords: catecholaminergic, dorsal vagal complex, nucleus of the solitary tract, stress, visceral


the mammalian brain stem contains several distinct groups of noradrenergic (NA) neurons that were initially described by Dahlström and Fuxe (59) who labeled the groups A1 through A7 as they extend from the caudal ventrolateral medulla through the rostral lateral pons. NA neurons collectively project throughout the central nervous system and are broadly implicated in behavioral and physiological processes related to attention, arousal, motivation, learning and memory, and homeostasis. NA neurons are distinguished by positive immunolabeling for tyrosine hydroxylase (TH), the rate-limiting enzyme for dopamine synthesis, and dopamine-β-hydroxylase (DbH), the enzyme that converts dopamine to norepinephrine (NE) (8). Conversely, neurons comprising the A1-A7 cell groups are not immunopositive for phenylethanolamine N-methyltransferase (PNMT). PNMT catalyzes the synthesis of epinephrine from NE, and its presence is used to identify adrenergic neurons of the C1-C3 cell groups (59).

This review focuses on the A2 cell group, a fascinating collection of NA neurons contained within the dorsal vagal complex (DVC) in the caudal dorsomedial medulla (see Fig. 1). As discussed further, below, the intra-DVC location of A2 neurons supports their known involvement in vagal sensory-motor reflex arcs and vagal motor outflow to multiple visceral targets. Perhaps less well appreciated is the role of A2 neurons in processes as diverse as satiation, sickness behavior, affective state, endocrine and behavioral stress responses, immune-to-brain signaling, emotional learning, memory consolidation, and addictive drug dependence. A2 neurons participate in reciprocal connections between the visceral DVC and other medullary, pontine, diencephalic, and telencephalic brain regions that underlie these diverse processes. Direct projections from the cortex, limbic forebrain, and hypothalamus to the region of the A2 cell group provide a route through which emotional and cognitive events can modulate visceral responses to diverse threats and opportunities to which the organism is exposed, including conditioned responses that are based on past experience (193, 225). In turn, ascending projections from A2 neurons provide a route through which interoceptive feedback from the body impacts not only hypothalamic functions but also emotional and cognitive processing (21, 141, 211, 225).

Fig. 1.

Fig. 1.

Immunoperoxidase localization of dopamine-β-hydroxylase (DbH; left) and phenylethanolamine N-methyltransferase (PNMT; right ) within the caudal dorsomedial medulla of an adult male Sprague-Dawley rat. Side-by-side panels represent closely adjacent tissue sections. Top 4: caudal levels of the A2 cell group (∼14.6 mm caudal to bregma). Bottom 4: most rostral levels (∼13.3 mm caudal to bregma). DbH-positive neurons within the A2 cell group are indicated by arrows. AP, area postrema; cc, central canal; DMV, dorsal motor nucleus of the vagus; NST, nucleus of the solitary tract; 4, fourth ventricle.

The neuroanatomical and phenotypic features of A2 neurons will first be considered in this review, followed by a summary of evidence that A2 neurons provide a critical brain-body interface linking emotional/cognitive events with physiological support, especially during stressful events that challenge bodily homeostasis. This general theme will be supported by briefly reviewing the involvement of A2 neurons in food intake, affective behavior, stress responses, emotional learning, and drug dependence. Most of the information reviewed in this article was derived from studies using rats and, to a lesser extent, mice; however, central NA circuits are highly conserved across mammalian species. Thus, understanding the functional organization of the A2 cell group in rodents has clinical relevance, and should contribute to a better understanding of stress-related physiological and emotional dysregulation in humans.

Anatomical and Neurochemical Features

Location of A2 neurons.

The A2 cell group is centered within intermediate and caudal levels of the nucleus of the solitary tract (NST) (Fig. 1), referred to as the visceral NST to distinguish these levels from the more rostral gustatory NST (143). The visceral NST is a key component of the DVC, which also includes the area postrema (AP) and dorsal motor nucleus of the vagus. The DVC is a critical central node for controlling hormonal and autonomic outflow, and relaying interoceptive feedback from body to brain (201, 205, 206, 291). The AP and a significant portion of the medial NST underlying the AP contain fenestrated capillaries, allowing blood-borne factors (e.g., hormones, toxins, cytokines) to affect A2 and other neurons local to this region. Within the DVC, AP neurons innervate the subjacent NST, and NST neurons innervate other NST neurons as well as vagal preganglionic parasympathetic neurons whose cell bodies occupy the dorsal motor nucleus of the vagus and whose dendrites ramify widely within the NST (239). All three components of the DVC also receive extrinsic neural inputs from the periphery and brain, described further, below.

Although the A2 cell group is centered within the visceral NST, A2 neurons are not confined to cytoarchitecturally-distinct NST subnuclei. Instead, they form two bilaterally symmetrical loose linear columns of medium-sized ovoid or multipolar cells that extend rostrocaudally through the visceral NST (232) (Fig. 1). A2 neurons are most prevalent within the medial subnucleus of the NST at the rostrocaudal level of the AP, but they also exist within the NST commissural subnucleus at the level of the AP and more caudally. Furthermore, some A2 neurons are located within and just lateral to the cytoarchitectural boundaries of the dorsal motor nucleus of the vagus (232). The most caudal A2 neurons are located in the upper cervical spinal cord, and the most rostral are located rostral to the AP at the level of the caudal fourth ventricle (Fig. 1). It should here be noted that the more rostral A2 neurons are intermixed with PNMT-positive adrenergic neurons of the C2 cell group (Figs. 1 and 2), which also are TH- and DbH-positive. Many of the neuroanatomical and functional studies cited in this review relied on anatomical localization together with TH or DbH immunolabeling to identify and/or lesion A2 neurons; however, these criteria do not allow A2 and C2 neurons to be distinguished within visceral NST regions where they overlap. The extent to which the connections and functions of these rostral A2/caudal C2 neurons are similar or unique remains largely unexplored.

Fig. 2.

Fig. 2.

Dual immunofluorescence labeling for DbH (red) and PNMT (green) in a tissue section through the rat dorsomedial medulla (∼13.3 mm caudal to bregma) where neurons of the A2 and C2 cell groups intermingle. 4, fourth ventricle.

Transmitter coexpression by A2 neurons.

When considering the functional role of A2 projection systems, it's important to keep in mind that these NA neurons release more than just NE from their axon terminals and varicosities. In addition to TH and DbH, A2 neurons express mRNA and/or are immunopositive for many additional signaling molecules. In rats, ∼80% of A2 neurons reportedly express mRNA for a homolog of the vesicular glutamate transporter-2 (248), suggesting that these neurons release glutamate along with NE. In addition, virtually all A2 neurons are immunoreactive for prolactin-releasing peptide (PrRP) (52). PrRP receptors are expressed within the paraventricular nucleus of the hypothalamus (PVN) and other brain regions targeted by A2 neurons (284), and there is evidence that PrRP acts synergistically with NE to activate hypophysiotropic corticotropin-releasing hormone (CRH) neurons at the apex of the hypothalamic-pituitary-adrenal (HPA) axis (147, 261). Interestingly, the ratios of PrRP to NA biosynthetic enzymes in A2 neurons are modulated by estrogen and stress (235), and A2 neurons express receptors for estrogen and glucocorticoids (56, 101, 198, 243).

Regarding other peptides and phenotypic markers, subpopulations of A2 neurons are immunopositive for neuropeptide Y (83, 233), nesfatin-1 (23), dynorphin (40), neurotensin (200), and/or pituitary adenylate cyclase-activating polypeptide (61). Conversely, A2 neurons apparently do not colocalize galanin (136), somatostatin (226, 227), enkephalin (226), inhibin-β (226), glucagon-like peptide 1 (133, 203), or the enzyme 11-β-hydroxysteroid dehydrogenase-2 (99), despite their close anatomical proximity to NST neurons, which do express these various phenotypic markers. A2 neurons also do not appear to coexpress cocaine and amphetamine-related transcript, neurotensin, or cholecystokinin, in contrast to coexpression of these peptides by PNMT-positive neurons of the partially overlapping C2 cell group (84, 122).

Receptor expression by A2 neurons.

Neurons within the A2 region of the visceral NST express receptor mRNA and binding sites for a large number of neurotransmitters and other signaling molecules, although confirmation of receptor expression by identified A2 neurons is relatively limited. The available data indicate that A2 neurons express α-2a adrenergic receptors (154, 221) as well as receptors for glutamate (6, 89), GABA (116), cannabinoids (38), CRH (171), neuropeptide Y (288), leptin (80), glucocorticoids (219), and estrogen (56, 198, 243). A2 neurons do not express mineralocorticoid receptors (99).

Extrinsic Inputs and Axonal Projections

Sensory inputs to A2 neurons.

In addition to local axonal inputs from the superjacent AP that are positioned to relay blood-borne signals to A2 neurons (54, 118, 238), the A2 region of the visceral NST receives sensory feedback from the cardiovascular, respiratory, and alimentary systems (119). These visceral sensory inputs arrive predominantly via glutamatergic glossopharyngeal and vagal afferents whose central axons converge in the solitary tract before synapsing with the dendrites and somata of NST and vagal motor neurons (5, 14, 208, 246). In mice, ∼90% of A2 neurons receive direct synaptic input from visceral afferents in the solitary tract (6). These glutamatergic inputs produce tightly synced, large-amplitude excitatory postsynaptic currents in A2 neurons, providing high-fidelity transmission of sensory afferent activity (6). Other visceral and somatic sensory inputs are relayed to the A2 region of the NST from the spinal cord, trigeminal and related nuclei, and reticular formation (5, 7, 71, 152, 153).

Given the diversity of sensory inputs received by A2 neurons, it is not surprising that they respond to a broad array of interoceptive signals, including hormonal, osmotic, gastrointestinal, cardiovascular, respiratory, and inflammatory signals (20, 23, 43, 45, 66, 77, 97, 112, 120, 167, 168, 201, 202, 207, 212, 213, 230). In these and many other studies, stimulus-induced A2 neuronal activation is characterized by immunocytochemical localization of the immediate-early gene product, Fos, together with immunolabeling for TH or DbH. Increased Fos immunolabeling alone cannot reveal the circuits through which A2 neurons are recruited by a given stimulus or event, but A2 neurons are consistently activated by treatments or situations that present actual or anticipated threats to bodily homeostasis. In many cases the relevant information is communicated to A2 neurons by visceral sensory afferents, but in other cases A2 neurons appear to be recruited by descending inputs from the hypothalamus and limbic forebrain (30, 67, 68, 137, 138). These inputs are reviewed in the following section.

Central inputs to A2 neurons.

Retrograde and anterograde tract-tracing studies have revealed a wide array of brain stem and forebrain nuclei that project directly to the visceral NST and may participate in recruitment of A2 neurons. As summarized in Table 1, these include various regions of the medullary, pontine, and mesencephalic reticular formation (13, 157, 166, 180); the cerebellar fastigial nucleus (180); the raphé obscurus, pallidus, magnus, paragigantocellularis, and parapyramidal region (144, 180, 256); the laterodorsal tegmental nucleus (180); the retrotrapezoid nucleus (220); the parabrachial nucleus and Kölliker-Fuse nucleus (130, 180); the periaqueductal gray (180); the hypothalamic tuberomammillary nuclei (182); the hypothalamic arcuate nucleus (266, 295); the PVN (100, 204, 228, 245, 266); the lateral hypothalamic area (180, 266, 294); the median preoptic nucleus (180); the dorsomedial hypothalamus (287); the central nucleus of the amygdala (CeA) and anterolateral bed nucleus of the stria terminalis (alBST) (116, 140, 180, 222, 266); the lateral septal nucleus (180); and glutamatergic pyramidal neurons in the insular cortex and in prelimbic and infralimbic regions of the medial prefrontal cortex (266). All of these brain regions are logical candidates for sources of direct input to A2 neurons, although dual-labeling electron microscopy is necessary to confirm synaptic connectivity. The limited ultrastructural evidence that is available indicates that at least a subset of A2 neurons receive synaptic input from noncatecholaminergic neurons in the adjacent AP (118), and at least some A2 neurons receive glutamatergic inputs from the infralimbic region of the medial prefrontal cortex (94). It also seems likely that A2 neurons are among the catecholaminergic neurons within the visceral NST that receive synaptic input from the CeA (189) and from orexin-positive neurons in the lateral hypothalamus (17).

Table 1.

Central connections of the A2 region of the dorsal vagal complex

Central Connections
∙ Spinal cord, cranial nerves
    Dorsal horn and lamina X
    Glossopharyngeal and vagal sensory afferents (via solitary tract)
∙ Medulla, Pons, and Midbrain
    Dorsal motor nucleus of the vagus
    Nucleus ambiguous
    Area postrema
    Trigeminal and related nuclei
    Medullary, pontine, mesencephalic reticular formation
    Raphé obscurus, pallidus, magnus, paragigantocellularis, and parapyramidal region
    Locus coeruleus and peri-locus coeruleus region
    Cerebellar fastigial nucleus
    Parabrachial nucleus
    Kölliker-Fuse nucleus
    Laterodorsal tegmental nucleus
    Ventral tegmental area
    Retrorubral field
    Retrotrapezoid nucleus
    Periaqueductal gray
∙ Thalamus and hypothalamus
    Midline thalamic nuclei
    Tuberomammillary nucleus
    Arcuate nucleus
    Paraventricular nucleus
    Lateral hypothalamic area
    Dorsomedial nucleus
    Median preoptic nucleus
    Supraoptic nucleus
    Subfornical organ
∙ Telencephalon
    Central nucleus of the amygdala
    Anterolateral bed nucleus of the stria terminalis
    Substantia innominata
    Nucleus accumbens
    Lateral septal nucleus
    Insular cortex
    Medial prefrontal cortex

Italicized = source of axonal input to the A2 region; Underlined = target of A2 axonal projections; Bold = both a source of axonal input to the A2 region and a target of A2 axonal projections. Citations are provided in text.

Axonal projections of A2 neurons.

A2 neurons project locally within the DVC and medullary reticular formation, and comprise a subset of preautonomic NST neurons implicated in vagal control of cardiovascular and digestive functions (77, 110, 146, 184, 218, 259). Dual-labeling retrograde tracing studies indicate that identified A2 neurons also project to multiple higher brain regions (201), as summarized in Table 1. These regions include the parabrachial nucleus, locus coeruleus (LC) and peri-LC region, periaqueductal gray, ventral tegmental area and retrorubral field, midline thalamic nuclei, tuberomammillary nucleus, arcuate nucleus, dorsomedial nucleus of the hypothalamus, PVN (Fig. 3), lateral hypothalamic area, median preoptic nucleus, subfornical organ, supraoptic nucleus, CeA, alBST, substantia innominata, and nucleus accumbens (NAcc) (14, 46, 82, 96, 104, 105, 116, 121, 158, 199201, 232, 253, 254, 272).

Fig. 3.

Fig. 3.

Dual immunofluorescence labeling of anterogradely-transported Phaseolus vulgaris leucoagglutinin (PhAL) neural tracer (green) and DbH (red) identifying axons in the medial parvocellular (mp) and lateral magnocellular (lm) subregions of the paraventricular nucleus of the hypothalamus (PVN). PhAL was microinjected iontophoretically into a portion of the A2 region in an adult male Sprague-Dawley rat 14 days before death (see Ref. 201).

Regarding the central targets of A2 axonal projections, it is useful to know that synaptic junctions may not be the primary release site for NE and other signaling molecules that are synthesized by A2 neurons. TH- and DbH-positive NA terminals within the PVN and other brain regions targeted by A2 neurons have been observed to form classical type I and type II synaptic inputs to postsynaptic structures; however, the incidence of nonsynaptic NA varicosities in these regions is much higher (15, 46, 82, 175, 187, 190). Thus, A2 neurons may release their transmitter synaptically and in a paracrine manner, requiring that NE and other costored transmitters must diffuse short distances through the extracellular space to bind to cognate receptors (cf. Ref. 190).

A subset of individual A2 neurons have axon collaterals that innervate both the PVN as well as the CeA and/or alBST in rats (16, 20, 185, 234). In addition, some A2 neurons project both to brain stem autonomic regions and to limbic forebrain targets (197). Interestingly, however, different brain stem autonomic regions appear to be targeted by different sets of A2 neurons (111), suggesting a higher degree of anatomical specificity for brain stem projections vs. hypothalamic and limbic forebrain projections of A2 neurons.

A2 axonal projections that ascend rostrally beyond the medulla do so primarily within the ventral NA bundle (VNAB) (4, 95, 156, 160, 231, 250, 276). It's relevant to note here that non-NA projections from the NST to the caudal ventrolateral medulla (111) allow visceral signals to recruit NA neurons of the A1 cell group (14, 111, 123, 260, 286), located at the same rostrocaudal level as the more dorsally situated A2 cell group. Some A1 and non-NA neurons within the ventrolateral medulla project back to the DVC (157) to participate in vagal motor outflow to the stomach (109, 110) and presumably other visceral targets, but the axons of many A1 neurons join A2 projections within the VNAB (44, 230, 232). The extent to which A1 and A2 projection targets are similar or distinct remains ripe for investigation, although there is evidence that they target phenotypically distinct neurons and subregions of the PVN and supraoptic nuclei (195, 196, 232). In the absence of specific evidence to discriminate between A1 and A2 neurons, a conservative approach dictates that projections and functions ascribed to either cell group should be considered likely shared by the other. The following sections review several examples of functions in which A2 neurons have been implicated, but the reader should consider that A1 neurons also are likely to be involved in at least a subset of these functions.

A2 Neurons and Food Intake

Central NA signaling pathways, including those that arise from A2 neurons, appear to be essential for inhibiting or stimulating food intake under different conditions (2, 62, 142, 156, 170, 203, 209, 214, 216). It seems likely that different subpopulations of A2 neurons with distinct axonal projections are recruited by signals that increase or decrease food intake, perhaps because different subpopulations target different brain regions, and/or because different combinations of adrenergic receptors are expressed within those regions (277). Interestingly, A2 neurons in rats appear to be activated in every experimental situation in which food intake is inhibited, including normal satiety (37, 115, 203, 207, 262). A2 neurons are recruited in a graded manner in rats after voluntary food intake, such that larger meals activate larger numbers of A2 neurons (207). Not only are A2 neurons robustly activated in rats after systemic administration of cholecystokinin octapeptide (210, 213) (Fig. 4), they are necessary for the ability of cholecystokinin to inhibit food intake and to activate neurons within the hypothalamic PVN (203). A2 neurons also contribute importantly to the hypophagic effect of lithium chloride (209). Food intake is reduced in rats after central administration of PrRP (134) or nesfatin-1 (174), each of which is coexpressed by A2 neurons (23, 52). A2 neurons are robustly activated by experimental treatments or situations that produce hypophagia or anorexia as a part of the depressive-like sickness behavior accompanying systemic infection or visceral malaise (23, 9698, 201, 202). These conditions also are associated with inhibition of vagally mediated gastric emptying, which likely underlies or contributes to hypophagia (37, 202, 203). The potential involvement of A2 neurons in other aspects of food intake and regulation of body energy homeostasis are the subject of a recent review (201).

Fig. 4.

Fig. 4.

Dual immunoperoxidase labeling of cFos protein (blue/black nuclear label) and cytoplasmic DbH (brown label) within the caudal visceral NST. This section was taken from a rat perfused with fixative 60 min after intraperitoneal administration of cholecystokinin octapeptide (100 μg/kg body wt) to stimulate vagal sensory inputs to the NST. Arrows point out activated (i.e., cFos-positive) A2 neurons (see Refs. 210 and 213).

A2 Neurons, the LC, and Affective Behavior

The trajectory and targets of NA fibers within the VNAB are distinct from those of the dorsal NA bundle, which originates from neurons within the pontine LC (A4 and A6 cell group regions). The vast majority of publications considering the role of central NA signaling in stress, cognition, and affective processes emphasize the LC and its projection targets, and either disregard or downplay the contributions of A2 neurons and their projections. The LC is assumed to be the principle source of the central NA signaling that underlies not only behavioral arousal but also HPA axis hyperactivity associated with stress (4850, 289) as well as the dysregulated NA transmission that contributes to diverse models of stress vulnerability and affective disorders (9, 51). However, NA inputs to the PVN, CeA, alBST, and NAcc that are critical for hormonal, behavioral, and affective responses to physiologically significant events arise from the caudal medullary A1 and A2 cell groups, with relatively little input from the LC (70, 230, 232). When clinical researchers measure growth hormone responses to an adrenergic agent (e.g., clonidine) to indirectly assess brain NA signaling in individuals with stress-related affective disorders (1, 72, 241, 242), it is primarily NA signaling by medullary A1/A2 inputs to the hypothalamus that is being assessed (47, 81, 165, 282), not LC inputs. Furthermore, results from a recent retrograde tracing and VNAB lesion study indicate that the majority of NA inputs to reward-related midbrain dopamine neurons arise from the caudal medulla, including the A2 cell group (151). Conversely, A2 neurons do not innervate most of the brain regions that are innervated by the LC, including the olfactory bulb, cerebral cortex, hippocampus, medial BST, basolateral amygdala, most thalamic nuclei, and the cerebellum (163). Moreover, NA signaling within LC-innervated brain regions can produce behavioral effects that are quite different from those produced by NA signaling within A2-innervated regions. For example, α-adrenergic receptor activation underlies positively motivated exploratory/approach behavior in cortical and subcortical regions innervated by the LC, but underlies stress reactions with behavioral inhibition in regions innervated by the A2 cell group (29, 41, 42, 69, 164, 192, 215, 247, 277, 278).

Neurons within the A2 region of the visceral NST project to the LC (201), but project more densely to the peri-LC region where the dendrites of LC neurons cluster, synapsing there on TH-positive dendrites (264, 265). As mentioned previously, A2 neurons coexpress PrRP immunolabeling (52), and the LC contains PrRP-positive fibers and terminals as well as the receptor (UHR-1) for PrRP (284). While the evidence is indirect, these findings indicate that A2 neurons may provide modulatory control over NA neurons within the LC, thereby indirectly modifying NA signaling within cortical, hippocampal, amygdalar, thalamic, and cerebellar targets of the LC. Interestingly, despite the LC-centered focus of most research on the role of NA brain systems in affective behavior, researchers have not been able to demonstrate unequivocally the necessity of LC neurons in fear, anxiety, or depressive-like behavior (114). Indeed, LC lesions appear to increase, rather than decrease, novelty-induced fear and anxiety in rats (103, 148). Moreover, in one study, LC lesions increased the antidepressant-like effect of reboxetine (a NE reuptake inhibitor), whereas VNAB lesions abolished the drug's antidepressant effects (53). These results invite a continued expansion of research into the role of A2 neurons and their central projections in affective behavior.

A2 Neurons and Stress Responses

Stressors are stimuli or events that challenge (or are perceived to challenge) bodily homeostasis and well-being. Signals generated by stressors may initially arrive from the environment (e.g., visual or olfactory signals), or may arise from within the body (e.g., cardiovascular or gastrointestinal signals). Physiological and behavioral responses to stressful stimuli are the product of interactions among multiple brain regions (107, 108). However, three interconnected regions of the hypothalamus and so-called extended amygdala are especially important, and have been the subject of extensive experimental attention: the medial parvocellular PVN (mpPVN), CeA, and alBST. Each region contains CRH neurons that receive synaptic input from NA terminals arising primarily or exclusively from the A2 (and A1) cell groups, and CRH neuronal activity within each region is closely regulated by these inputs (4, 10, 65, 74, 78, 79, 124, 126128, 139, 181, 186, 191, 192, 244). A2 neurons express glucocorticoid receptors (101), and central adrenergic and CRH receptors are regulated by glucocorticoids, which are known to affect NE synthesis and turnover throughout the brain. NA-CRH signaling pathways are viewed as part of a central adrenal steroid-sensitive network that tunes physiological and behavioral responses during conditions of acute or chronic stress (106). In general, and as discussed further, below, NA signaling is pivotal in facilitating HPA axis and behavioral responses to stress, and can modulate unconditioned and conditioned behavioral responses to stressful and emotional stimuli, including stimuli that evoke fear and anxiety (223). Enhanced NA transmission in human subjects is associated with enhanced HPA axis responses to stress, which may contribute to the psychopathology of depression, anxiety, and other affective disorders (128). The hindbrain A2 cell group appears to be a fundamental player in these central mechanisms, as summarized in the following sections.

PVN.

Most hypothalamic NA input arrives from medullary NA cell groups. A2 neurons appear to selectively target the mpPVN (55, 230, 232), although axonal projections from the A2 region to the lateral magnocellular PVN also are common (see Fig. 3 and discussion in the following section). The necessity of NA inputs for HPA axis responses to stress appears to vary across different types of stress stimuli (20, 66, 137, 224, 229), but NA input to the mpPVN, arriving via the VNAB, provides the major known stimulus for CRH synthesis and release (65, 181, 192, 250, 283). CRH is the principal and obligate hypophysiotropic peptide driving the pituitary-adrenal axis under basal conditions and in response to homeostatic challenge (192, 274).

In rats, stressful stimuli that activate A2 neurons and recruit the HPA axis also activate hypothalamic oxytocin neurons (177, 178, 206, 263, 267269). CRH and oxytocin neurons receive direct synaptic input from NA terminals, and NA inputs increase CRH and oxytocin excitability (3, 4, 22, 113, 155, 192, 195, 196, 217, 285). In late pregnancy and during lactation, oxytocin and HPA axis responses to stressors are attenuated by mechanisms that reduce NA tone within the PVN (2628, 76, 257, 258). Lesions that decrease NA input to the mpPVN markedly attenuate CRH neuronal responses to interoceptive signals (20, 90, 137, 203, 209, 215, 234). Conversely, chronic stress sensitizes HPA axis responses to central NA (183) and increases the density of glutamatergic and NA synaptic inputs to CRH-positive neurons, evidence for enhanced signaling capacity (86). The authors of the latter study did not consider whether the increased glutamatergic and NA inputs arise from the same A2 neurons, but this seems likely.

Magnocellular oxytocin neurons and parvocellular thyrotropin releasing hormone-positive mpPVN neurons also receive synaptic input from the A2 cell group (57, 58, 93, 240, 283). In addition, nonendocrine gastric preautonomic neurons in the PVN receive direct synaptic input from NA nerve terminals that include inputs from A2 neurons (15). Preautonomic PVN neurons project to hindbrain and spinal centers to control autonomic motor outflow to the gastrointestinal tract and other organ systems (16, 87, 204, 251) to thereby shape visceral responses to emotive stimuli and stress (228, 292).

alBST.

The anterolateral group of BST nuclei (alBST) includes the juxtacapsular, oval, rhomboid, fusiform, and subcommissural zone (75). The alBST is connected with autonomic-related portions of the hypothalamus and caudal medulla, and receives an extremely dense NA innervation that arises from A2 (and A1) neurons, but not from the LC (11, 25, 69, 74, 75, 186188, 252, 275). NA acts within the alBST to modulate behavioral, hormonal, and conditioned emotional responses to stress (41, 179), including, for example, responses to the stress of precipitated opiate withdrawal (11, 78). The alBST also receives input from the hippocampus and prefrontal cortex, and has abundant projections to the mpPVN (74). At least a subset of A2 neurons that innervate the alBST have axon collaterals that target the mpPVN (16, 20), and NA signaling within the alBST contributes to stress-induced HPA axis activation (88, 135). Certain aspects of BST-mediated anxiety responses appear to depend on CRH inputs from the amygdala (63, 270, 271) with which the alBST is strongly and reciprocally connected (73). Blockade of NA signaling in the ventral alBST reduces immobilization stress-induced anxiety in the elevated-plus maze and attenuates immobilization stress-induced increases in plasma ACTH, but the same pharmacological manipulation has no effect to attenuate stress responses in a subsequent social interaction test (41); the reverse is true for similar manipulations in the CeA (42). These findings suggest that A2 inputs to the alBST and CeA are involved in different specific components of stress and anxiety responses (cf. Ref. 244).

CeA.

The CeA, like the alBST, is a subcortical limbic structure characterized by its extensive connections with the hypothalamus and with brain stem viscerosensory and autonomic control nuclei. As part of the striatal amygdala, CeA neurons are primarily GABAergic and coexpress CRH, similar to neurons in the alBST (73, 249). Although NA inputs to the CeA are significantly less dense than NA inputs to the mpPVN and alBST (16, 167, 169), NA signaling within the CeA modulates behavioral responses to stressful events, including fear, anxiety, and avoidance behavior (64, 125). NA signaling in the CeA increases during precipitated opiate withdrawal and contributes to the negative affective (i.e., aversive) consequences of withdrawal (273), similar to increased NA signaling and implication in aversive effects within the alBST (11). A2 neurons that project to the CeA are activated in rats after gastric vagal sensory stimulation with exogenous cholecystokinin (169) or systemic immune challenge (97), and also are activated by emotionally salient exteroceptive stimuli, such as exposure to a predator odor (168).

A2 Neurons and Emotional Learning

The effectiveness with which emotionally significant experiences are encoded into long-term memory is dependent, at least in part, on interoceptive feedback from body to brain, and increased NA signaling within the limbic forebrain is strongly implicated in emotional learning (3135, 85, 161, 162, 279, 280). As reviewed earlier in this article, interoceptive signals funneled through the hindbrain DVC engage A2 neurons, including those that project to the amygdala and NAcc. Both limbic regions play a crucial role in the encoding, storage, and retrieval of memories associated with emotionally significant events. Activation of NA receptors within the amygdala and NAcc influences synaptic changes that are necessary at the time of encoding to facilitate long-term memory for emotional events (85, 124). NE release in the amygdala has been established as a neural substrate for memory modulation elicited by peripheral arousal (85, 280, 281), and NA inputs to the NAcc contribute importantly to the processing of appetitive and aversive reinforcement signals that impact learning and memory (70). Neurons within the amygdala and NAcc respond to gastric and cardiovascular vagal sensory signals that engage the A2 cell group (126, 150, 159). These A2 inputs play a key role in modulating amygdalar and NAcc activity by releasing NA in response to heightened states of arousal, providing a clear anatomical route through which emotional (i.e., visceral) signals can modulate learning and memory (124).

A2 inputs to other brain regions may affect learning and memory in a more indirect manner. For example, A2 inputs to NA neurons in the LC (264, 265) and to dopamine neurons in the midbrain retrorubral field (151) that innervate the entorhinal cortex and hippocampus may contribute to the modulation of declarative and spatial memory processes.

A2 Neurons in Drug Use and Dependence

Central neural adaptations elicited by exposure to addictive drugs are not limited to brain reward circuits, but also are manifest in stress-related pathways that are implicated in addiction (173). For example, rats dependent on morphine display increased enzymatic activity of A2 neurons and increased NA turnover within the PVN, concurrent with enhanced activity of the HPA axis that depends on NA input (18, 92, 131, 132, 172). In addition, medullary NA inputs to the alBST, CeA, and NAcc are critical for the aversiveness of acute opiate withdrawal, and for stress-induced relapse of drug seeking for opiates, cocaine, ethanol, and nicotine (11, 24, 36, 69, 78, 145, 244, 293). NA inputs to the alBST trigger GABAergic inhibition of alBST neurons that project to the ventral tegmental area, which likely contributes to the inhibition of DA neurons that occurs during opiate withdrawal (78). Thus, common inputs to the hypothalamus and limbic forebrain from the A2 cell group could be a critical factor linking these brain areas in circuits that underlie drug use and dependence (102, 236, 237). Even 5 wk after opiate withdrawal, neurons within these limbic forebrain regions remain hypersensitive to drug-related cues and stress, which may drive behavior away from the pursuit of natural rewards, such as food and sex, and toward drug-related rewards to thereby perpetuate a cycle of drug addiction (102). Clinical observations of former opiate addicts revealed a prolonged hyper-responsiveness to stress, including altered cortisol release (129), which may be at least partly due to altered function of A2 signaling pathways. For example, A2-to-NAcc projection neurons are similarly activated by noxious visceral stimuli and by precipitated opiate withdrawal (69, 117), and the same projection pathway is implicated in cannabinoid modulation of NAcc activity and cannabinoid-induced aversion (38, 39).

Increased NA release within the extended amygdala continues to influence stress and anxiety systems in the brain for some time following acute drug withdrawal, even after somatic signs dissipate (91). Interestingly, conditioned preference for morphine is absent in DbH knock-out mice in which NE synthesis is interrupted, but preference is restored if DbH is rescued to restore NA signaling within and from the NTS, but not the LC (176). Repeated nicotine self-administration increases NA receptor sensitivity in the PVN and also enhances HPA function (290). Collectively, it seems that NA signaling from the A2 cell group to the hypothalamus and limbic forebrain contributes to mechanisms that support drug seeking and self-administration, increased anxiety during drug abstinence, altered reward processing (i.e., dysphoria), and the general relationship between the use of mood-altering drugs and mood disorders (12, 38, 78, 131, 176, 244).

Conclusion

The diverse challenges and opportunities of life elicit a constellation of autonomic, endocrine, cognitive, and behavioral responses, and A2 neurons are poised to contribute to the central coordination and modulation of these responses. As reviewed in this article, feedback regarding the body's physiological state is relayed by A2 neurons to multiple regions of the brain stem, hypothalamus, and limbic forebrain. The A2 cell group is best defined by its afferent and efferent connections within a complex neural network that extends from the spinal cord to the cortex. The available evidence indicates that by virtue of their central axonal projections, this relatively small group of caudal medullary neurons can modulate ongoing and future physiological processes and behaviors, and may also contribute to the affective, contextual, and cognitive attributes of experience that depend on interoceptive feedback from body to brain (19, 60, 149, 194, 255).

GRANTS

This manuscript was prepared with the support of National Institute of Mental Health Grants MH-59911 and MH-081817.

DISCLOSURES

No conflicts of interest, financial or otherwise, are declared by the author(s).

REFERENCES

  • 1. Abelson JL, Cameron OG. Adrenergic dysfunction in anxiety disorders. In: Adrenergic Dysfunction and Psychobiology, edited by Cameron OG. Washington, DC: American Psychiatric Press, 1994 [Google Scholar]
  • 2. Ahlskog JE, Hoebel BG. Overeating and obesity from damage to a noradrenergic system in the brain. Science 182: 166–169, 1973 [DOI] [PubMed] [Google Scholar]
  • 3. Al-Damluji S. Adrenergic mechanisms in the control of corticotropin secretion. J Endocrinol 119: 5–14, 1988 [DOI] [PubMed] [Google Scholar]
  • 4. Alonso G, Szafarczyk A, Balmefrezol M, Assenmacher I. Immunocytochemical evidence of stimulatory control by the ventral noradrenergic bundle of parvicellular neurons of the paraventricular nucleus secreting corticotropin-releasing hormone and vasopressin in rats. Brain Res 397: 297–307, 1986 [DOI] [PubMed] [Google Scholar]
  • 5. Altschuler SM, Bao X, Bieger D, Hopkins DA, Miselis RR. Viscerotopic representation of the upper alimentary tract in the rat: sensory ganglia and nuclei of the solitary and spinal trigeminal tracts. J Comp Neurol 283: 248–268, 1989 [DOI] [PubMed] [Google Scholar]
  • 6. Appleyard SM, Marks D, Kobayashi K, Okano H, Low MJ, Andresen MC. Visceral afferents directly activate catecholamine neurons in the solitary tract nucleus. J Neurosci 27: 13292–13302, 2007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Arbab MA, Delgado T, Wiklund L, Svendgaard NA. Brain stem terminations of the trigeminal and upper spinal ganglia innervation of the cerebrovascular system: WGA-HRP transganglionic study. J Cereb Blood Flow Metab 8: 54–63, 1988 [DOI] [PubMed] [Google Scholar]
  • 8. Armstrong DM, Ross CA, Pickel VP, Joh TH, Reis DJ. Distribution of dopamine, noadrenaline and adrenaline-containing cell bodies in the rat medulla oblongata: demonstration by immunocytochemical localization of catecholamine biosynthetic enzymes. J Comp Neurol 211: 173–187, 1982 [DOI] [PubMed] [Google Scholar]
  • 9. Asakura M, Nagashima H, Fujii S, Sasuga Y, Misonoh A, Hasegawa H, Osada K. Influences of chronic stress on central nervous systems. Jpn J Psychopharmacol 20: 97–105, 2000 [PubMed] [Google Scholar]
  • 10. Asan E, Yilmazer-Hanke DM, Eliava M, Hantsch M, Lesch KP, Schmitt A. The corticotropin-releasing factor (CRF)-system and monoaminergic afferents in the central amygdala: investigations in different mouse strains and comparison with the rat. Neuroscience 131: 953–967, 2005 [DOI] [PubMed] [Google Scholar]
  • 11. Aston-Jones G, Delfs JM, Druhan J, Zhu Y. The bed nucleus of the stria terminalis: a target site for noradrenergic actions in opiate withdrawal. Ann NY Acad Sci 877: 486–498, 1999 [DOI] [PubMed] [Google Scholar]
  • 12. Aston-Jones G, Harris GC. Brain substrates for increased drug seeing during protracted withdrawal. Neuropsychopharmacology 47, Suppl 1: 167–179, 2004 [DOI] [PubMed] [Google Scholar]
  • 13. Babic T, de Oliveira CV, Ciriello J. Collateral axonal projections from rostral ventromedial medullary nitric oxide synthase containing neurons to brainstem autonomic sites. Brain Res 1211: 2008 [DOI] [PubMed] [Google Scholar]
  • 14. Bailey TW, Hermes SM, Andresen MC, Aicher AA. Cranial visceral afferent pathways through the nucleus of the solitary tract to caudal ventrolateral medulla or paraventricular hypothalamus: target-specific synaptic reliability and convergence patterns. J Neurosci 26: 11893–11902, 2006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Balcita-Pedicino JJ, Rinaman L. Noradrenergic axon terminals contact gastric pre-autonomic neurons in the paraventricular nucleus of the hypothalamus in rats. J Comp Neurol 501: 608–618, 2007 [DOI] [PubMed] [Google Scholar]
  • 16. Banihashemi L, Rinaman L. Noradrenergic inputs to the bed nucleus of the stria teminalis and paraventricular nucleus of the hypothalamus underlie hypothalamic-pituitary-adrenal axis but not hypophagic or conditioned avoidance responses to systemic yohimbine. J Neurosci 26: 11442–11453, 2006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Barrera G, Hernandez A, Poulin JF, Laforest S, Drolet G, Morilak DA. Galanin-mediated anxiolytic effect in rat central amygdala is not a result of corelease from noradrenergic terminals. Synapse 59: 27–40, 2006 [DOI] [PubMed] [Google Scholar]
  • 18. Benavides M, Laorden ML, García-Borrón JC, Milanés MV. Regulation of tyrosine hydroxylase levels and activity and Fos expression during opioid withdrawal in the hypothalamic PVN and medulla oblongata catecholaminergic cell groups innervating the PVN. Eur J Neurosci 17: 103–112, 2003 [DOI] [PubMed] [Google Scholar]
  • 19. Berntson GG, Sarter M, Cacioppo JT. Ascending visceral regulation of cortical affective information processing. Eur J Neurosci 18: 2103–2109, 2003 [DOI] [PubMed] [Google Scholar]
  • 20. Bienkowski MS, Rinaman L. Noradrenergic inputs to the paraventricular hypothalamus contribute to hypothalamic-pituitary-adrenal axis and central Fos activation in rats after acute systemic endotoxin exposure. Neuroscience 156: 1093–1102, 2008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Blessing WW. The Lower Brainstem and Bodily Homeostasis. New York: Oxford University Press, 1997 [Google Scholar]
  • 22. Bojo L, Cassuto J, Nellgard P. Pain-induced inhibition of gastric motility is mediated by adrenergic and vagal non-adrenergic reflexes in the rat. Acta Physiol Scand 146: 377–383, 1992 [DOI] [PubMed] [Google Scholar]
  • 23. Bonnet MS, Pecchi E, Trouslard J, Jean A, Dallaporta M, Troadec JD. Central nesfatin-1-expressing neurons are sensitive to peripheral inflammatory stimulus. J Neuroinflammation 6: 27, 2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Brown ZJ, Tribe E, D'souza NA, Erb S. Interaction between noradrenaline and corticotrophin-releasing factor in the reinstatement of cocaine seeking in the rat. Psychopharmacologia 203: 121–130, 2009 [DOI] [PubMed] [Google Scholar]
  • 25. Brownstein MJ, Palkovits M. Catecholamines, serotonin, acetylcholine, and γ-aminobutyric acid in the rat brain: biochemical studies. In: Handbook of Chemical Neuroanatomy, edited by Bjorklund A, Hokfelt T. Amsterdam: Elsevier, 1984, p. 23–54 [Google Scholar]
  • 26. Brunton PJ, McKay AJ, Ochedalski T, Piastowska A, Rebas E, Lachowicz A, Russell JA. Central opioid inhibition of neuroendocrine stress responses in pregnancy in the rat is induced by the neurosteroid allopregnanolone. J Neurosci 29: 6449–6460, 2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Brunton PJ, Russell JA. Attenuated hypothalamo-pituitary-adrenal axis responses to immune challenge during pregnancy: the neurosteroid-opioid connection. J Physiol 586: 369–375, 2008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Brunton PJ, Russell JA. Keeping oxytocin neurons under control during stress in pregnancy. Prog Brain Res 170: 365–377, 2008 [DOI] [PubMed] [Google Scholar]
  • 29. Buller K, Xu Y, Dayas C, Day T. Dorsal and ventral medullary catecholamine cell groups contribute differentially to systemic interleukin-1β-induced hypothalamic pituitary adrenal axis responses. Neuroendocrinology 73: 129–138, 2001 [DOI] [PubMed] [Google Scholar]
  • 30. Buller KM, Dayas CV, Day TA. Descending pathways from the paraventricular nucleus contribute to the recruitment of brainstem nuclei following a systemic immune challenge. Neuroscience 118: 189–203, 2003 [DOI] [PubMed] [Google Scholar]
  • 31. Cahill L, Babinsky R, Markowitsch HJ, McGaugh JL. The amygdala and emotional memory. Nature 377: 295–296, 1995 [DOI] [PubMed] [Google Scholar]
  • 32. Cahill L, McGaugh JL. Amygdaloid complex lesions differentially affect retention of tasks using appetitive and aversive reinforcement. Behav Neurosci 104: 532–543, 1990 [DOI] [PubMed] [Google Scholar]
  • 33. Cahill L, McGaugh JL. Mechanisms of emotional arousal and lasting declarative memory. Trends Neurosci 21: 294–299, 1998 [DOI] [PubMed] [Google Scholar]
  • 34. Cahill L, McGaugh JL. A novel demonstration of enhanced memory associated with emotional arousal. Conscious Cogn 4: 410–421, 1995 [DOI] [PubMed] [Google Scholar]
  • 35. Cahill L, Prins B, Weber M, McGaugh JL. β-Adrenergic activation and memory for emotional events. Nature 371: 702–704, 1994 [DOI] [PubMed] [Google Scholar]
  • 36. Caillé S, Espejo EF, Reneric JP, Cador M, Koob GF, Stinus L. Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal. J Pharmacol Exp 290: 881–892, 1999 [PubMed] [Google Scholar]
  • 37. Callahan JB, Rinaman L. The postnatal emergence of dehydration anorexia in rats is temporally associated with the emergence of dehydration-induced inhibition of gastric emptying. Physiol Behav 64: 683–687, 1998 [DOI] [PubMed] [Google Scholar]
  • 38. Carvalho AF, Mackie K, Van Bockstaele EJ. Cannabinoid modulation of limbic forebrain noradrenergic circuitry. Eur J Neurosci 31: 286–301, 2010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Carvalho AF, Reyes ARS, Sterling RC, Unterwald E, Van Bockstaele EJ. Contribution of limbic norepinephrine to cannabinoid-induced aversion. Psychopharmacology (Berl) 211: 479–491, 2010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Ceccatelli S, Seroogyb KB, Millhornc DE, Tereniusd L. Presence of a dynorphin-like peptide in a restricted subpopulation of catecholaminergic neurons in rat nucleus tractus solitarii. Brain Res 589: 225–230, 1992 [DOI] [PubMed] [Google Scholar]
  • 41. Cecchi M, Khoshbouei H, Javors M, Morilak DA. Modulatory effects of norepinephrine in the lateral bed nucleus of the stria terminalis on behavioral and neuroendocrine responses to acute stress. Neuroscience 112: 13–21, 2002 [DOI] [PubMed] [Google Scholar]
  • 42. Cecchi M, Khoshbouei H, Morilak DA. Modulatory effects of norepinephrine, acting on α1 receptors in the central nucleus of the amygdala, on behavioral and neuroendocrine responses to acute immobilization stress. Neuropharmacology 43: 1139–1147, 2002 [DOI] [PubMed] [Google Scholar]
  • 43. Chan RK, Sawchenko PE. Spatially and temporally differentiated patterns of c-fos expression in brainstem catecholaminergic cell groups induced by cardiovascular challenges in the rat. J Comp Neurol 348: 433–460, 1994 [DOI] [PubMed] [Google Scholar]
  • 44. Chan RKW, Peto CA, Sawchenko PE. A1 catecholamine cell group: fine structure and synaptic input from the nucleus of the solitary tract. J Comp Neurol 351: 62–80, 1995 [DOI] [PubMed] [Google Scholar]
  • 45. Chan RKW, Sawchenko PE. Organization and transmitter specificity of medullary neurons activated by sustained hypertension: implications for understanding baroreceptor reflex circuitry. J Neurosci 18: 371–387, 1998 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Chang HT. Noradrenergic innervation of the substantia innominata: a light and electron microscopic analysis of dopamine β-hydroxylase immunoreactive elements in the rat. Exp Neurol 104: 101–112, 1989 [DOI] [PubMed] [Google Scholar]
  • 47. Chapman IM, Kapoor R, Willoughby JO. Endogenous catecholamines modulate growth hormone release in the conscious rat during hypoglycaemia but not in the basal state. J Neuroendocrinol 5: 145–150, 1993 [DOI] [PubMed] [Google Scholar]
  • 48. Charney DS, Grillon C, Bremner JD. The neurobiological basis of anxiety and fear: circuits, mechanisms, and neurochemical interactions (part I). Neuroscientist 4: 35–44, 1998 [Google Scholar]
  • 49. Charney DS, Grillon CCG, Bremner JD. The neurobiological basis of anxiety and fear: circuits, mechanisms, and neurochemical interactions (part II). Neuroscientist 4: 122–132, 1998 [Google Scholar]
  • 50. Charney DS, Grillon CCG, Bremner JD. The neurobiological basis of anxiety and fear: circuits, mechanisms, and neurochemical interactions (part III). Neuroscientist 4: 122–132, 1998 [Google Scholar]
  • 51. Charney DS, Heninger GR, Redmond JDE. Yohimbine induced anxiety and increased noradrenergic function in humans: effects of diazepam and clonidine. Life Sci 33: 19–29, 1983 [DOI] [PubMed] [Google Scholar]
  • 52. Chen CT, Dun SL, Dun NJ, Chang JK. Prolactin-releasing peptide-immunoreactivity in A1 and A2 noradrenergic neurons of the rat medulla. Brain Res 822: 276–279, 1999 [DOI] [PubMed] [Google Scholar]
  • 53. Cryan JF, Page ME, Lucki I. Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test. Eur J Pharmacol 436: 197–205, 2002 [DOI] [PubMed] [Google Scholar]
  • 54. Cunningham ET, Jr, Miselis RR, Sawchenko PE. The relationship of efferent projections from the area postema to vagal motor and brain stem catecholamine-containing cell groups: an axonal transport and immunohistochemical study in the rat. Neuroscience 58: 635–648, 1994 [DOI] [PubMed] [Google Scholar]
  • 55. Cunningham ET, Jr, Sawchenko PE. Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus. J Comp Neurol 274: 60–76, 1988 [DOI] [PubMed] [Google Scholar]
  • 56. Curran-Rauhut MA, Petersen SL. Oestradiol-dependent and -independent modulation of tyrosine hydroxylase mRNA levels in subpopulations of A1 and A2 neurones with oestrogen receptor (ER)α and ERβ gene expression. J Neuroendocrinol 15: 296–303, 2003 [DOI] [PubMed] [Google Scholar]
  • 57. Daftary SS, Boudaba C, Szabo K, Tasker JG. Noradrenergic excitation of magnocellular neurons in the rat hypothalamic paraventricular nucleus via intranuclear glutamatergic circuits. J Neurosci 18: 10619–10628, 1998 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58. Daftary SS, Boudaba C, Tasker JG. Noradrenergic regulation of parvocellular neurons in the rat hypothalamic paraventricular nucleus. Neuroscience 96: 743–751, 2000 [DOI] [PubMed] [Google Scholar]
  • 59. Dahlström A, Fuxe K. Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol Scand 62, Suppl 232: 3–55, 1964 [PubMed] [Google Scholar]
  • 60. Damasio A. The Feeling of What Happens: Body and Emotion in the Making of Consciousness. New York: Harcourt Brace, 1999 [Google Scholar]
  • 61. Das M, Vihlen CS, Legradi G. Hypothalamic and brainstem sources of pituitary adenylate cyclase-activating polypeptide nerve fibers innervating the hypothalamic paraventricular nucleus in the rat. J Comp Neurol 500: 761–776, 2007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62. Date Y, Shimbara T, Koda S, Toshinai K, Ida T, Murakami N, Miyazato M, Kokame K, Ishizu kaIshida Y, Kageyama H, Shioda S, Kangawa K, Nakazato M. Peripheral ghrelin transmits orexigenic signals through the noradrenergic pathway from the hindbrain to the hypothalamus. Cell Metab 4: 323–331, 2006 [DOI] [PubMed] [Google Scholar]
  • 63. Davis M. Are different parts of the extended amygdala involved in fear versus anxiety? Biol Psychiatry 44: 1239–1247, 1998 [DOI] [PubMed] [Google Scholar]
  • 64. Davis M, Rainnie D, Cassell M. Neurotransmission in the rat amygdala related to fear and anxiety. Trends Neurosci 17: 208–214, 1994 [DOI] [PubMed] [Google Scholar]
  • 65. Day T, Ferguson AV, Renaud L. Noradrenergic afferents facilitate the activity of tuberoinfundibular neurons of the hypothalamic paraventricular nucleus. Neuroendocrinology 41: 17–22, 1985 [DOI] [PubMed] [Google Scholar]
  • 66. Dayas CV, Buller KM, Crane JW, Xu Y, Day TA. Stressor categorization: acute physical and psychological stressors elicit distinctive recruitment patterns in the amygdala and in medullary noradrenergic cell groups. Eur J Neurosci 14: 1143–1152, 2001 [DOI] [PubMed] [Google Scholar]
  • 67. Dayas CV, Buller KM, Day TA. Hypothalamic paraventricular nucleus neurons regulate medullary catecholamine cell responses to restraint stress. J Comp Neurol 478: 22–34, 2004 [DOI] [PubMed] [Google Scholar]
  • 68. Dayas CV, Day TA. Opposing roles for medial and central amygdala in the initiation of noradrenergic cell responses to a psychological stressor. Eur J Neurosci 15: 1712–1718, 2001 [DOI] [PubMed] [Google Scholar]
  • 69. Delfs JM, Zhu Y, Druhan JP, Aston-Jones G. Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature 403: 430–434, 2000 [DOI] [PubMed] [Google Scholar]
  • 70. Delfs JM, Zhu Y, Druhan JP, Aston-Jones GS. Origin of noradrenergic afferents to the shell subregion of the nucleus accumbens: anterograde and retrograde tract-tracing studies in the rat. Brain Res 806: 127–140, 1998 [DOI] [PubMed] [Google Scholar]
  • 71. de Sousa Buck H, Caous CA, Lindsey CJ. Projections of the paratrigeminal nucleus to the ambiguus, rostroventrolateral and lateral reticular nuclei, and the solitary tract. Auton Neurosci 87: 187–200, 2001 [DOI] [PubMed] [Google Scholar]
  • 72. Dinan TG, Barry S, Ahkion S, Chua A, Keeling PW. Assessment of central noradrenergic functioning in irritable bowel syndrome using a neuroendocrine challenge test. J Psychosom Res 43: 575–580, 1990 [DOI] [PubMed] [Google Scholar]
  • 73. Dong HW, Petrovich GD, Swanson LW. Topography of projections from amygdala to bed nuclei of the stria terminalis. Brain Res Rev 38: 192–246, 2001 [DOI] [PubMed] [Google Scholar]
  • 74. Dong HW, Petrovich GD, Watts AG, Swanson LW. Basic organization of projections from the oval and fusiform nuclei of the bed nuclei of the stria terminalis in adult rat brain. J Comp Neurol 436: 430–455, 2001 [DOI] [PubMed] [Google Scholar]
  • 75. Dong HW, Swanson LW. Organization of axonal projections from the anterolateral area of the bed nucleus of the stria terminalis. J Comp Neurol 468: 277–298, 2004 [DOI] [PubMed] [Google Scholar]
  • 76. Douglas AJ. Central noradrenergic mechanisms underlying acute stress responses of the hypothalamo-pituitary-adrenal axis: adaptations through pregnancy and lactation. Stress 8: 5–18, 2005 [DOI] [PubMed] [Google Scholar]
  • 77. Duale H, Waki H, Howorth P, Kasparov S, Teschemacher AG, Paton JFR. Restraining influence of A2 neurons in chronic control of arterial pressure in spontaneously hypertensive rats. Cardiovasc Res 76: 184–193, 2007 [DOI] [PubMed] [Google Scholar]
  • 78. Dumont EC, Williams JT. Noradrenaline triggers GABAA inhibition of bed nucleus of the stria terminalis neurons projecting to the ventral tegmental area. J Neurosci 24: 8198–8204, 2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79. Dunn AJ, Swiergiel AH, Palamarchouk V. Brain circuits involved in corticotropin-releasing factor-norepinephrine interactions during stress. Ann NY Acad Sci 1018: 25–34, 2004 [DOI] [PubMed] [Google Scholar]
  • 80. Ellacott KLJ, Lawrence CB, Rothwell NJ, Luckman SM. PRL-releasing peptide interacts with leptin to reduce food intake and body weight. Endocrinology 143: 368–374, 2002 [DOI] [PubMed] [Google Scholar]
  • 81. Emanuel AJ, Ritter S. Hindbrain catecholamine neurons modulate the growth hormone but not the feeding response to ghrelin. Neuroendocrinology 151: 3237–3246, 2010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82. Ericson H, Blomqvist A, Köhler C. Brainstem afferents to the tuberomammillary nucleus in the rat brain with special reference to monoaminergic innervation. J Comp Neurol 281: 169–192, 1989 [DOI] [PubMed] [Google Scholar]
  • 83. Everitt BJ, Hökfelt T. The coexistence of neuropeptide-Y with other peptides and amines in the central nervous system. In: Neuropeptide Y, edited by Mutt V, Fuxe K, Hökfelt T, Lundberg JM. New York: Raven, 1989, p. 61–71 [Google Scholar]
  • 84. Fekete C, Wittman G, Liposits Z, Lechan RM. Origin of cocaine- and amphetamine-regulated transcript (CART)-immunoreactive innervation of the hypothalamic paraventricular nucleus. J Comp Neurol 469: 340–350, 2004 [DOI] [PubMed] [Google Scholar]
  • 85. Ferry B, Roozendaal B, McGaugh JL. Role of norepinephrine in mediating stress hormone regulation of long-term memory storage: a critical involvement of the amygdala. Biol Psychiatry 46: 1140–1152, 1999 [DOI] [PubMed] [Google Scholar]
  • 86. Flak JN, Ostrander MM, Tasker JG, Herman JP. Chronic stress-induced neurotransmitter plasticity in the PVN. J Comp Neurol 517: 156–165, 2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87. Flanagan LM, Verbalis JG, Stricker EM. Effects of anorexigenic treatments on gastric motility in rats. Am J Physiol Regul Integr Comp Physiol 256: R955–R961, 1989 [DOI] [PubMed] [Google Scholar]
  • 88. Forray MI, Gysling K. Role of noradrenergic projections to the bed nucleus of the stria terminalis in the regulation of the hypothalamic-pituitary-adrenal axis. Brain Res Rev 47: 145–160, 2004 [DOI] [PubMed] [Google Scholar]
  • 89. Forray MI, Gysling K, Andres ME, Bustos G, Araneda S. Medullary noradrenergic neurons projecting to the bed nucleus of the stria terminalis express mRNA for the NMDA-NR1 receptor. Brain Res Bull 52: 163–169, 2000 [DOI] [PubMed] [Google Scholar]
  • 90. Fraley GS, Ritter S. Immunolesion of norepinephrine and epinephrine afferents to medial hypothalamus alters basal and 2-deoxy-d-glucose-induced neuropeptide Y and agouti gene-related protein messenger ribonucleic acid expression in the arcuate nucleus. Endocrinology 144: 75–83, 2003 [DOI] [PubMed] [Google Scholar]
  • 91. Fuentealba JA, Forray MI, Gysling K. Chronic morphine treatment and withdrawal increase extracellular levels of norepinephrine in the rat bed nucleus of the stria terminalis. J Neurochem 75: 741–748, 2000 [DOI] [PubMed] [Google Scholar]
  • 92. Fuertes G, Laorden ML, Milanés MV. Noradrenergic and dopaminergic activity in the hypothalamic paraventricular nucleus after naloxone-induced morphine withdrawal. Neuroendocrinology 71: 60–67, 2000 [DOI] [PubMed] [Google Scholar]
  • 93. Füzesi T, Wittmann G, Lechan RM, Liposits Z, Fekete C. Noradrenergic innervation of hypophysiotropic thyrotropin-releasing hormone synthesizing neurons in rats. Brain Res 1294: 38–44, 2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94. Gabbott PL, Warner T, Busby SJ. Catecholaminergic neurons in medullary nuclei are among the post-synaptic targets of descending projections from infralimbic area 25 of the rat medial prefrontal cortex. Neuroscience 144: 623–635, 2007 [DOI] [PubMed] [Google Scholar]
  • 95. Gaillet S, Alonso G, LeBorgne R, Barbanel G, Malaval F, Assenmacher I, Szafarczyk A. Effects of discrete lesions in the ventral noradrenergic ascending bundle on the corticotropic stress response depend on the site of the lesion and on the plasma levels of adrenal steroids. Neuroendocrinology 58: 408–419, 1993 [DOI] [PubMed] [Google Scholar]
  • 96. Gaykema RP, Park SM, McKibbin CR, Goehler LE. Lipopolysaccharide suppresses activation of the tuberomammillary histaminergic system concomitant with behavior: a novel target of immune-sensory pathways. Neuroscience 152: 273–287, 2008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97. Gaykema RPA, Chen CC, Goehler LE. Organization of immune-responsive medullary projections to the bed nucleus of the stria terminalis, central amygdala, and paraventricular nucleus of the hypothalamus: evidence for parallel viscerosensory pathways in the rat brain. Brain Res 1130: 130–145, 2007 [DOI] [PubMed] [Google Scholar]
  • 98. Gaykema RPA, Daniels TE, Shapiro NJ, Thacker GC, Park SM, Goehler LE. Immune challenge and satiety-related activation of both distinct and overlapping neuronal populations in the brainstem indicate parallel pathways for viscerosensory signaling. Brain Res 1294: 61–79, 2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99. Geerling JC, Kawata M, Loewy AD. Aldosterone-sensitive neurons in the rat central nervous system. J Comp Neurol 494: 515–527, 2006 [DOI] [PubMed] [Google Scholar]
  • 100. Geerling JC, Shin JW, Chimenti PC, Loewy AD. Paraventricular hypothalamic nucleus: axonal projections to the brainstem. J Comp Neurol 518: 1460–1499, 2010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101. Härfstrand A, Fuxe K, Cintra A, Agnati LF, Zini I, Wikström AC, Okret S, Yu ZY, Goldstein M, Steinbusch H, Verhofstad A, Gustafsson JA. Glucocorticoid receptor immunoreactivity in monoaminergic neurons of rat brain. Proc Natl Acad Sci USA 83: 9779–9783, 1986 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102. Harris GC, Aston-Jones G. Activation in extended amygdala corresponds to altered hedonic processing during protracted morphine withdrawal. Behav Brain Res 176: 251–258, 2007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103. Harro J, Oreland L, Vasar E, Bradwejn J. Impaired exploratory behavior after DSP-4 treatment in rats: implications for the increased anxiety after noradrenergic denervation. Eur Neuropsychopharmacol 5: 447–455, 1995 [DOI] [PubMed] [Google Scholar]
  • 104. Herbert H, Moga MM, Saper CB. Connections of the parabrachial nucleus with the nucleus of the solitary tract and the medullary reticular formation in the rat. J Comp Neurol 293: 540–580, 1990 [DOI] [PubMed] [Google Scholar]
  • 105. Herbert H, Saper CB. Cholecystokinin-, galanin-, and corticotropin-releasing factor-like immunoreactive projections from the nucleus of the solitary tract to the parabrachial nucleus in the rat. J Comp Neurol 293: 581–598, 1990 [DOI] [PubMed] [Google Scholar]
  • 106. Herman JP, Cullinan WE. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci 20: 78–84, 1997 [DOI] [PubMed] [Google Scholar]
  • 107. Herman JP, Figueiredo H, Mueller NK, Ulrich-Lai Y, Ostrander MM, Choi DC, Cullinan WE. Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front Neuroendocrinol 24: 151–180, 2003 [DOI] [PubMed] [Google Scholar]
  • 108. Herman JP, Ostrander MM, Mueller NK, Figueiredo H. Limbic system mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis. Prog Neuro-Psychopharm Biol Psych 29: 1201–1213, 2005 [DOI] [PubMed] [Google Scholar]
  • 109. Herman MA, Niedringhaus M, Alayan A, Verbalis JG, Sahibzada N, Gillis RA. Characterization of noradrenergic transmission at the dorsal motor nucleus of the vagus involved in reflex control of fundus tone. Am J Physiol Regul Integr Comp Physiol 294: R720–R729, 2008 [DOI] [PubMed] [Google Scholar]
  • 110. Hermann GE, Nasse JS, Rogers RC. α-1 Adrenergic input to solitary nucleus neurones: calcium oscillations, excitation and gastric reflex control. J Physiol 562: 553–568, 2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 111. Hermes SM, Mitchell JL, Aicher SA. Most neurons in the nucleus tractus solitarii do not send collateral projections to multiple autonomic targets in the rat brain. Exp Neurol 198: 539–551, 2006 [DOI] [PubMed] [Google Scholar]
  • 112. Hollis JH, Lightman SL, Lowry CA. Integration of systematic and visceral sensory information by medullary catecholaminergic systems during peripheral inflammation. Ann NY Acad Sci 1018: 71–75, 2004 [DOI] [PubMed] [Google Scholar]
  • 113. Horie S, Shioda S, Nakai Y. Catecholaminergic innervation of oxytocin neurons in the paraventricular nucleus of the rat hypothalamus as revealed by double-labeling immunoelectron microscopy. Acta Anat (Basel) 147: 184–192, 1993 [DOI] [PubMed] [Google Scholar]
  • 114. Itoi K, Sugimoto N. The brainstem noradrenergic systems in stress, anxiety and depression. J Neuroendocrinol 22: 355–361, 2010 [DOI] [PubMed] [Google Scholar]
  • 115. Jelsing J, Galzin AM, Guillot E, Pruniaux MP, Larsen PJ, Vrang N. Localization and phenotypic characterization of brainstem neurons activated by rimonabant and WIN55,212–2. Brain Res Bull 78: 202–210, 2009 [DOI] [PubMed] [Google Scholar]
  • 116. Jia HG, Rao ZR, Shi JW. Evidence of g-aminobutyric acidergic control over the catecholaminergic projection from the medulla oblongata to the central nucleus of the amygdala. J Comp Neurol 381: 262–281, 1997 [DOI] [PubMed] [Google Scholar]
  • 117. Jin GR, Rao ZR, Shi JW. Visceral noxious stimulation induced expression of Fos protein in medullary catecholaminergic neurons projecting to nucleus accumbens in the rat: a study with triple labelig method of HRP tracing combined with Fos and TH immunohistochemistry. Brain Res 648: 196–202, 1985 [DOI] [PubMed] [Google Scholar]
  • 118. Kachidian P, Pickel VM. Localization of tyrosine hydroxylase in neuronal targets and efferents of the area postrema in the nucleus tractus solitarii of the rat. J Comp Neurol 329: 337–353, 1993 [DOI] [PubMed] [Google Scholar]
  • 119. Kalia M, Sullivan JM. Brainstem projections of sensory and motor components of the vagus nerve in the rat. J Comp Neurol 211: 248–265, 1982 [DOI] [PubMed] [Google Scholar]
  • 120. Kasparov S, Teschemacher AG. Altered central catecholaminergic transmission and cardiovascular disease. Exp Physiol 93: 725–740, 2008 [DOI] [PubMed] [Google Scholar]
  • 121. Kawai Y, Takagi H, Yanai K, Tohyama M. Adrenergic projection from the caudal part of the nucleus of the tractus solitarius to the parabrachial nucleus in the rat: immunocytochemical study combined with a retrograde tracing method. Brain Res 459: 369–372, 1988 [DOI] [PubMed] [Google Scholar]
  • 122. Kawaia Y, Takagi H, Tohyama M. Co-localization of neurotensin- and cholecystokinin-like immunoreactivities in catecholamine neurons in the rat dorsomedial medulla. Neuroscience 24: 227–236, 1988 [DOI] [PubMed] [Google Scholar]
  • 123. Kawano H, Masuko S. Neurons in the caudal ventrolateral medulla projecting to the paraventricular hypothalamic nucleus receive synaptic inputs from the nucleus of the solitary tract: a light and electron microscopic double-labeling study in the rat. Neurosci Lett 218: 33–36, 1996 [DOI] [PubMed] [Google Scholar]
  • 124. Kerfoot EC, Chattillion EA, Williams CL. Functional interactions between the nucleus tractus solitarius (NTS) and nucleus accumbens shell in modulating memory for arousing experiences. Neurobiol Learn Mem 89: 47–60, 2008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 125. Khoshbouei H, Cecchi M, Dove S, Javors M, Morilak DA. Behavioral reactivity to stress: amplification of stress-induced noradrenergic activation elicits a galanin-mediated anxiolytic effect in central amygdala. Pharmacol Biochem 71: 407–417, 2002 [DOI] [PubMed] [Google Scholar]
  • 126. Kirouac GJ, Ciriello J. Medullary inputs to nucleus accumbens neurons. Am J Physiol Regul Integr Comp Physiol 273: R2080–R2088, 1997 [DOI] [PubMed] [Google Scholar]
  • 127. Kitazawa S, Shioda S, Nakai Y. Catecholaminergic innervation of neurons containing corticotropin-releasing factor in the paraventricular nucleus of the rat hypothalamus. Acta Anat (Basel) 129: 337–343, 1987 [PubMed] [Google Scholar]
  • 128. Koob GF. Corticotropin-releasing factor, norepinephrine, and stress. Biol Psychiatry 46: 1167–1180, 1999 [DOI] [PubMed] [Google Scholar]
  • 129. Kreek MJ, Koob GF. Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend 51: 23–47, 1998 [DOI] [PubMed] [Google Scholar]
  • 130. Krukoff TL, Harris KH, Jhamandas JH. Efferent projections from the parabrachial nucleus demonstrated with the anterograde tracer Phaseolus vulgaris leucoagglutinin. Brain Res Bull 30: 163–172, 1993 [DOI] [PubMed] [Google Scholar]
  • 131. Laorden ML, Fuertes G, González-Cuello A, Milanés MV. Changes in catecholaminergic pathways inervating paraventricular nucleus and pituitary-adrenal axis responses during morphine dependence: implication of α1- and α2-adrenoceptors. J Pharmacol Exp 293: 578–584, 2000 [PubMed] [Google Scholar]
  • 132. Laorden ML, Núñez C, Almela P, Milanés MV. Morphine withdrawal-induced c-fos expression in the hypothalamic paraventricular nucleus is dependent on the activation of catecholaminergic neurones. J Neurochem 83: 132–140, 2002 [DOI] [PubMed] [Google Scholar]
  • 133. Larsen PJ, Tang-Christensen M, Holst JJ, Orskov C. Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in rat hypothalamus and brainstem. Neuroscience 77: 257–270, 1997 [DOI] [PubMed] [Google Scholar]
  • 134. Lawrence CB, Celsi F, Brennand J, Luckman SM. Alternative role for prolactin-releasing peptide in the regulation of food intake. Nature 3: 645–646, 2000 [DOI] [PubMed] [Google Scholar]
  • 135. Leri F, Flores J, Rodaros D, Stewart J. Blockade of stress-induced but not cocaine-induced reinstatement by infusion of noradrenergic antagonists into the bed nucleus of the stria terminalis or the central nucleus of the amygdala. J Neurosci 22: 5713–5718, 2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 136. Levin MC, Sawchenko PE, Howe PRC, Bloom SR, Polak JM. Organization of galanin-immunoreactive inputs to the paraventricular nucleus with special reference to their relationship to catecholaminergic afferents. J Comp Neurol 261: 562–582, 1987 [DOI] [PubMed] [Google Scholar]
  • 137. Li HY, Ericsson A, Sawchenko PE. Distinct mechanisms underlie activation of hypothalamic neurosecretory neurons and their medullary catecholaminergic afferents in categorically different stress paradigms. Proc Natl Acad Sci USA 93: 2359–2364, 1996 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 138. Li HY, Sawchenko PE. Hypothalamic effector neurons and extended circuitries activated in “neurogenic” stress: a comparison of footshock effects exerted acutely, chronically, and in animals with controlled glucocorticoid levels. J Comp Neurol 393: 244–266, 1998 [PubMed] [Google Scholar]
  • 139. Liposits Z, Phelix C, Paull WK. Adrenergic innervation of corticotropin releasing factor (CRF)-synthesizing neurons in the hypothalamic paraventricular nucleus of the rat. Histochemistry 84: 201–205, 1986 [DOI] [PubMed] [Google Scholar]
  • 140. Liubashina O, Jolkkonen E, Pitkanen A. Projections from the central nucleus of the amygdala to the gastric related area of the dorsal vagal complex: a Phaseolus vulgaris-leucoagglutinin study in rat. Neurosci Lett 291: 85–88, 2000 [DOI] [PubMed] [Google Scholar]
  • 141. Loewy AD. Central autonomic pathways. In: Central Regulation of Autonomic Functions, edited by Loewy AD, Spyer KM. New York: Oxford University Press, 1990, p. 88–103 [Google Scholar]
  • 142. Lorden J, Oltmans GA, Margules DL. Central noradrenergic neurons: differential effects on body weight of electrolytic and 6-hydroxydopamine lesions in rats. J Comp Physiol Psychol 90: 144–155, 1976 [DOI] [PubMed] [Google Scholar]
  • 143. Lundy RF, Jr, Norgren R. Gustatory system. In: The Rat Nervous System (3rd ed.), edited by Paxinos G. San Diego, CA: Elsevier Academic, 2004, p. 890–921 [Google Scholar]
  • 144. Lynn RB, Kreider MS, Miselis RR. Thyrotropin-releasing hormone-immunoreactive projections to the dorsal motor nucleus and the nucleus of the solitary tract of the rat. J Comp Neurol 311: 271–288, 1991 [DOI] [PubMed] [Google Scholar]
  • 145. Maldonado R. Participation of noradrenergic pathways in the expression of opiate withdrawal: biochemical and pharmacological evidence. Neurosci Biobehav Rev 21: 91–104, 1997 [DOI] [PubMed] [Google Scholar]
  • 146. Martinez-Peña-y-Valenzuela I, Rogers RC, Hermann GE, Travagli RA. Norepinephrine effects on identified neurons of the rat dorsal motor nucleus of the vagus. Am J Physiol Gastrointest Liver Physiol 286: G333–G339, 2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 147. Maruyama M, Matsumoto H, Fujiwara K, Noguchi J, Kitada C, Fujino M, Inoue K. Prolactin-releasing peptide as a novel stress mediator in the central nervous system. Endocrinology 142: 2032–2038, 2001 [DOI] [PubMed] [Google Scholar]
  • 148. Mason ST, Fibiger HC. Current concepts. I. Anxiety: the locus coeruleus disconnection. Life Sci 25: 2141–2147, 1979 [DOI] [PubMed] [Google Scholar]
  • 149. Mayer EA, Saper CB. (Editors). The Biological Basis for Mind Body Interactions. Amsterdam: Elsevier, 2000 [Google Scholar]
  • 150. Mehendale S, Xie JT, Aung HH, Guan XF, Yuan CS. Nucleus accumbens receives gastric vagal inputs. Acta Pharmacol Sin 25: 271–275, 2004 [PubMed] [Google Scholar]
  • 151. Mejías-Aponte CA, Drouin C, Astron-Jones G. Adrenergic and noradrenergic innervation of the midbrain ventral tegmental area and retrorubal field: prominent inputs from medullary homeostatic centers. J Neurosci 29: 3613–3626, 2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 152. Menétrey D, Basbaum AI. Spinal and trigeminal projections to the nucleus of the solitary tract: a possible substrate for somatovisceral and viscerovisceral reflex activation. J Comp Neurol 255: 439–450, 1987 [DOI] [PubMed] [Google Scholar]
  • 153. Menétrey D, de Pommery J. Origins of spinal ascending pathways that reach central areas involved in visceroception and visceronociception in the rat. Eur J Neurosci 3: 249–259, 1991 [DOI] [PubMed] [Google Scholar]
  • 154. Meyer H, Palchaudhuri M, Scheinin M, Flügge G. Regulation of α2A-adrenoceptor expression by chronic stress in neurons of the brain stem. Brain Res 880: 147–158, 2000 [DOI] [PubMed] [Google Scholar]
  • 155. Michaloudi HC, Majdoubi ME, Poulain DA, Papadopoulos GC, Theodosis DT. The noradrenergic innervation of identified hypothalamic magnocellular somata and its contribution to lactation-induced synaptic plasticity. J Neuroendocrinol 9: 17–23, 1997 [DOI] [PubMed] [Google Scholar]
  • 156. Milan MJ, Millan MH, Herz A. The role of the ventral noradrenergic bundle in relation to endorphins in the control of core temperature, open-field and ingestive behaviour in the rat. Brain Res 263: 283–294, 1983 [DOI] [PubMed] [Google Scholar]
  • 157. Millhorn DE, Seroogy K, Hökfelt T, Schmued LC, Terenius L, Buchan A, Brown JC. Neurons of the ventral medulla oblongata that contain both somatostatin and enkephalin immunoreactivities project to nucleus tractus solitarii and spinal cord. Brain Res 424: 99–108, 1987 [DOI] [PubMed] [Google Scholar]
  • 158. Milner TA, Joh TH, Pickel VM. Tyrosine hydroxylase in the rat parabrachial region: ultrastructural localization and extrinsic sources of immunoreactivity. J Neurosci 6: 2585–2603, 1986 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 159. Miranda MI, Ferreira G, Ramirez-Lugo L, Bermúdez-Rattoni F. Glutamatergic activity in the amygdala signals visceral input during taste memory formation. Proc Natl Acad Sci USA 99: 11417–11422, 2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 160. Miyahara S, Oomura Y. Inhibitory action of the ventral noradrenergic bundle on the lateral hypothalamic neurons through α-noradrenergic mechanisms in the rat. Brain Res 234: 459–463, 1982 [DOI] [PubMed] [Google Scholar]
  • 161. Miyashita T, Williams CL. Enhancement of noradrenergic neurotransmission in the nucleus of the solitary tract modulates memory storage processes. Brain Res 987: 164–175, 2003 [DOI] [PubMed] [Google Scholar]
  • 162. Miyashita T, Williams CL. Glutamatergic transmission in the nucleus of the solitary tract modulates memory through influences on amygdala noradrenergic systems. Behav Neurosci 116: 13–21, 2002 [DOI] [PubMed] [Google Scholar]
  • 163. Moore RY, Card JP. Noradrenaline-containing neuron systems. In: Handbook of Chemical Neuroanatomy, edited by Bj̈orklund A, Ḧokfelt T. Amsterdam: Elsevier, 1984, p. 123–156 [Google Scholar]
  • 164. Morilak DA, Barrera G, Echevarria DJ, Garcia AS, Hernandez A, Ma S, Petre CO. Role of brain norepinephrine in the behavioral response to stress. Prog Neuro-Psychopharm Biol Psych 29: 1214–1224, 2005 [DOI] [PubMed] [Google Scholar]
  • 165. Mounier F, Bluet-Pajot MT, Durand D, Kordon C, Epelbaum J. α1-Noradrenergic inhibition of growth hormone secretion is mediated through the paraventricular hypothalamic nucleus in male rats. Neuroendocrinology 59: 29–34, 1994 [DOI] [PubMed] [Google Scholar]
  • 166. Mtui EP, Anwar M, Reis DJ, Ruggiero DA. Medullary visceral reflex circuits: local afferents to nucleus tractus solitarii synthesize catecholamines and project to thoracic spinal cord. J Comp Neurol 351: 5–26, 1995 [DOI] [PubMed] [Google Scholar]
  • 167. Myers EA, Banihashemi L, Rinaman L. The anxiogenic drug yohimbine activates central viscerosensory circuits in rats. J Comp Neurol 492: 426–441, 2005 [DOI] [PubMed] [Google Scholar]
  • 168. Myers EA, Rinaman L. Trimethylthiazoline supports conditioned flavor avoidance and activates viscerosensory, hypothalamic, and limbic circuits in rats. Am J Physiol Regul Integr Comp Physiol 288: R1716–R1726, 2005 [DOI] [PubMed] [Google Scholar]
  • 169. Myers EA, Rinaman L. Viscerosensory activation of noradrenergic inputs to the amygdala in rats. Physiol Behav 77: 723–729, 2002 [DOI] [PubMed] [Google Scholar]
  • 170. Myers RD, McCaleb ML. Feeding: satiety signals from intestine trigger brain's noradrenergic mechanisms. Science 209: 1035–1037, 1980 [DOI] [PubMed] [Google Scholar]
  • 171. Navarro-Zaragoza J, Núñez C, Laorden ML, Milanés MV. Effects of corticotropin-releasing factor receptor-1 antagonists on the brain stress system responses to morphine withdrawal. Mol Pharmacol 77: 864–873, 2010 [DOI] [PubMed] [Google Scholar]
  • 172. Núñez C, Földes A, Pérez-Flores D, García-Borrón JC, Laorden ML, Kovács KJ, Milanés MV. Elevated glucocorticoid levels are responsible for induction of tyrosine hydroxylase mRNA expression, phosphorylation, and enzyme activity in the nucleus of the solitary tract during morphine withdrawal. Endocrinology 150: 3118–3127, 2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 173. Núñez C, Martín FAAF, Laorden ML, Kovács KJ, Milanés MV. Induction of FosB/DeltaFosB in the brain stress system-related structures during morphine dependence and withdrawal. J Neurochem 114: 475–487, 2010 [DOI] [PubMed] [Google Scholar]
  • 174. Oh-IS, Shimizu H, Satoh T, Okada S, Adachi S, Inoue K, Eguchi H, Yamamoto M, Imaki T, Hashimoto K, Tsuchiya T, Monden T, Horiguchi K, Yamada M, Mori M. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature (London) 443: 709–712, 2006 [DOI] [PubMed] [Google Scholar]
  • 175. Olschowka JA, Molliver ME, Grzanna R, Rice FL, Coyle JJ. Ultrastructural demonstration of noradrenergic synapses in the rat central neuron system by dopamine-β-hydroxylase immunocytochemistry. J Histochem Cytochem 29: 271–289, 1981 [DOI] [PubMed] [Google Scholar]
  • 176. Olson VG, Heusner CL, Bland RJ, During MJ, Weinshenker D, Palmiter RD. Role of noradrenergic signaling by the nucleus tractus solitarius in mediating opiate reward. Science 311: 1017–1020, 2006 [DOI] [PubMed] [Google Scholar]
  • 177. Onaka T. Neural pathways controlling central and peripheral oxytocin release during stress. J Neuroendocrinol 16: 308–312, 2004 [DOI] [PubMed] [Google Scholar]
  • 178. Onaka T, Palmer JR, Yagi K. A selective role of brainstem noradrenergic neurons in oxytocin release from the neurohypophysis following noxious stimuli in the rat. Neurosci Res 25: 67–75, 1996 [DOI] [PubMed] [Google Scholar]
  • 179. Onaka T, Yagi K. Role of noradrenergic projections to the bed nucleus of the stria terminalis in neuroendocrine and behavioral responses to fear-related stimuli in rats. Brain Res 788: 287–293, 1998 [DOI] [PubMed] [Google Scholar]
  • 180. Otake K, Reis DJ, Ruggiero DA. Afferents to the midline thalamus issue collaterals to the nucleus tractus solitarii: an anatomical basis for thalamic and visceral reflex integration. J Neurosci 14: 5694–5707, 1994 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 181. Pacak K, Palkovits M, Kopin IJ, Goldstein DS. Stress-induced norepinephrine release in the hypothalamic paraventricular nucleus and pituitary-adrenocortical and sympathoadrenal activity: in vivo microdialysis studies. Front Neuroendocrinol 16: 89–150, 1995 [DOI] [PubMed] [Google Scholar]
  • 182. Panula P, Pirvola U, Auvinen S, Airaksinen MS. Histamine-immunoreactive nerve fibers in the rat brain. Neuroscience 28: 585–610, 1989 [DOI] [PubMed] [Google Scholar]
  • 183. Pardon MC, Ma S, Morilak DA. Chronic cold stress sensitizes brain noradrenergic reactivity and noradrenergic facilitation of the HPA stress response in Wistar Kyoto rats. Brain Res 971: 55–65, 2003 [DOI] [PubMed] [Google Scholar]
  • 184. Pearson RJ, Gatti PJ, Sahibzada N, Massari VJ, Gillis RA. Ultrastructural evidence for selective noradrenergic innervation of CNS vagal projections to the fundus of the rat. Auton Neurosci 136: 31–42, 2007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 185. Petrov T, Krukoff TL, Jhamandas JH. Branching projections of catecholaminergic brainstem neurons to the paraventricular hypothalamic nucleus and the central nucleus of the amygdala in the rat. Brain Res 609: 81–92, 1993 [DOI] [PubMed] [Google Scholar]
  • 186. Phelix CF, Liposits Z, Paull WK. Catecholamine-CRF synaptic interaction in a septal bed nucleus: afferents of neurons in the bed nucleus of the stria terminalis. Brain Res Bull 33: 109–119, 1994 [DOI] [PubMed] [Google Scholar]
  • 187. Phelix CF, Liposits Z, Paull WK. Monoamine innervation of bed nucleus of stria terminalis: an electron microscopic investigation. Brain Res Bull 28: 949–965, 1992 [DOI] [PubMed] [Google Scholar]
  • 188. Phelix CF, Paull WK. Demonstration of distinct corticotropin releasing factor-containing neuron populations in the bed nucleus of the stria terminalis. A light and electron microscopic immunocytochemical study in the rat. Histochemistry 94: 345–364, 1990 [DOI] [PubMed] [Google Scholar]
  • 189. Pickel VM, Bockstaele EJv, Chan J, Cestari DM. Amygdala efferents form inhibitory-type synapses with a subpopulation of catecholaminergic neurons in the rat nucleus tractus solitarius. J Comp Neurol 362: 510–523, 1995 [DOI] [PubMed] [Google Scholar]
  • 190. Pickel VM, Nirenberg MJ, Milneer TA. Ultrastructural view of central catecholamine transmission: immunocytochemical localization of synthesizing enzymes, transporters and receptors. J Neurocytol 25: 843–856, 1996 [DOI] [PubMed] [Google Scholar]
  • 191. Plotsky P. Facilitation of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation after activation of catecholaminergic pathways or central norepinephrine injection. Endocrinology 121: 924–930, 1987 [DOI] [PubMed] [Google Scholar]
  • 192. Plotsky PM, Cunningham ET, Jr, Widmaier EP. Catecholaminergic modulation of corticotropin-releasing factor and adrenocorticotropin secretion. Endocr Rev 10: 437–458, 1989 [DOI] [PubMed] [Google Scholar]
  • 193. Price JL. Free will versus survival: brain systems that underlie intrinsic constraints on behavior. J Comp Neurol 493: 132–139, 2005 [DOI] [PubMed] [Google Scholar]
  • 194. Prinz JJ. Gut Reactions: A Perceptual Theory of Emotion. New York: Oxford University Press, 2004 [Google Scholar]
  • 195. Raby WN, Renaud LP. Dorsomedial medulla stimulation activates rat supraoptic oxytocin and vasopressin neurones through different pathways. J Physiol 417: 279–294, 1989 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 196. Raby WN, Renaud LP. Nucleus tractus solitarius innervation of supraoptic nucleus: anatomical and electrophysiological studies in the rat suggest differential innervation of oxytocin and vasopressin neurons. Prog Brain Res 81: 319–327, 1989 [DOI] [PubMed] [Google Scholar]
  • 197. Reyes BAS, Bockstaele EJV. Divergent projections of catecholaminergic neurons in the nucleus of the solitary tract to limbic forebrain and medullary autonomic brain regions. Brain Res 1117: 69–79, 2006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 198. Reyes BAS, Tsukamura H, I'Anson H, Amelita M, Estacio C, Hirunagi K, Maeda KI. Temporal expression of estrogen receptor-α in the hypothalamus and medulla oblongata during fasting: a role of noradrenergic neurons. J Endocrinol 190: 593–600, 2006 [DOI] [PubMed] [Google Scholar]
  • 199. Ricardo JA, Koh ET. Anatomical evidence of direct projections from the nucleus of the solitary tract to the hypothalamus, amygdala, and other forebrain structures in the rat. Brain Res 153: 1–26, 1978 [DOI] [PubMed] [Google Scholar]
  • 200. Riche D, Pommery JD, Menetrey D. Neuropeptides and catecholamines in efferent projections of the nuclei of the solitary tract in the rat. J Comp Neurol 293: 399–424, 1990 [DOI] [PubMed] [Google Scholar]
  • 201. Rinaman L. Ascending projections from the caudal visceral nucleus of the solitary tract to brain regions involved in food intake and energy expenditure. Brain Res 1350: 18–34, 2010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 202. Rinaman L. Hindbrain contributions to anorexia. Am J Physiol Regul Integr Comp Physiol 287: R1035–R1036, 2004 [DOI] [PubMed] [Google Scholar]
  • 203. Rinaman L. Hindbrain noradrenergic lesions attenuate anorexia and alter central cFos expression in rats after gastric viscerosensory stimulation. J Neurosci 23: 10084–10092, 2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 204. Rinaman L. Oxytocinergic inputs to the nucleus of the solitary tract and dorsal motor nucleus of the vagus in neonatal rats. J Comp Neurol 399: 101–109, 1998 [DOI] [PubMed] [Google Scholar]
  • 205. Rinaman L. Postnatal development of hypothalamic inputs to the dorsal vagal complex in rats. Physiol Behav 79: 65–70, 2003 [DOI] [PubMed] [Google Scholar]
  • 206. Rinaman L. Visceral sensory inputs to the endocrine hypothalamus. Front Neuroendocrinol 28: 50–60, 2007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 207. Rinaman L, Baker EA, Hoffman GE, Stricker EM, Verbalis JG. Medullary c-Fos activation in rats after ingestion of a satiating meal. Am J Physiol Regul Integr Comp Physiol 275: R262–R268, 1998 [DOI] [PubMed] [Google Scholar]
  • 208. Rinaman L, Card JP, Schwaber JS, Miselis RR. Ultrastructural demonstration of a gastric monosynaptic vagal circuit in the nucleus of the solitary tract in rat. J Neurosci 9: 1985–1996, 1989 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 209. Rinaman L, Dzmura V. Experimental dissociation of neural circuits underlying conditioned avoidance and hypophagic responses to lithium chloride. Am J Physiol Regul Integr Comp Physiol 293: R1495–R1503, 2007 [DOI] [PubMed] [Google Scholar]
  • 210. Rinaman L, Hoffman GE, Dohanics J, Le WW, Stricker EM, Verbalis JG. Cholecystokinin activates catecholaminergic neurons in the caudal medulla that innervate the paraventricular nucleus of the hypothalamus in rats. J Comp Neurol 360: 246–256, 1995 [DOI] [PubMed] [Google Scholar]
  • 211. Rinaman L, Schwartz GJ. Anterograde transneuronal viral tracing of central viscerosensory pathways in rats. J Neurosci 24: 2782–2786, 2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 212. Rinaman L, Stricker EM, Hoffman GE, Verbalis JG. Central c-fos expression in neonatal and adult rats after subcutaneous injection of hypertonic saline. Neuroscience 79: 1165–1175, 1997 [DOI] [PubMed] [Google Scholar]
  • 213. Rinaman L, Verbalis JG, Stricker EM, Hoffman GE. Distribution and neurochemical phenotypes of caudal medullary neurons activated to express cFos following peripheral administration of cholecystokinin. J Comp Neurol 338: 475–490, 1993 [DOI] [PubMed] [Google Scholar]
  • 214. Ritter S, Bugarith K, Dinh TT. Immunotoxic destruction of distinct catecholamine subgroups produces selective impairment of glucoregulatory responses and neuronal activation. J Comp Neurol 432: 197–216, 2001 [DOI] [PubMed] [Google Scholar]
  • 215. Ritter S, Watts AG, Dinh TT, Sanchez-Watts G, Pedrow C. Immunotoxin lesion of hypothalamically projecting norepinephrine and epinephrine neurons differentially affects circadian and stressor-stimulated corticosterone secretion. Endocrinology 144: 1357–1367, 2003 [DOI] [PubMed] [Google Scholar]
  • 216. Ritter S, Wise D, Stein L. Neurochemical regulation of feeding in the rat: facilitation by α-noradrenergic, but not dopaminergic, receptor stimulants. J Comp Physiol Psychol 88: 778–784, 1975 [DOI] [PubMed] [Google Scholar]
  • 217. Rivier CL, Plotsky PM. Mediation by corticotropin-releasing factor of adenohypophysial hormone secretion. Annu Rev Physiol 48: 475–494, 1986 [DOI] [PubMed] [Google Scholar]
  • 218. Rogers RC, Travagli RA, Hermann GE. Noradrenergic neurons in the rat solitary nucleus participate in the esophageal-gastric relaxation reflex. Am J Physiol Regul Integr Comp Physiol 285: R479–R489, 2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 219. Roozendaal B, Williams CL, McGaugh JL. Glucocorticoid receptor activation in the rat nucleus of the solitary tract facilitates memory consolidation: involvement of the basolateral amygdala. Eur J Neurosci 11: 1317–1323, 1999 [DOI] [PubMed] [Google Scholar]
  • 220. Rosin DL, Chang DA, Guyenet PG. Afferent and efferent connections of the rat retrotrapezoid nucleus. J Comp Neurol 499: 64–89, 2006 [DOI] [PubMed] [Google Scholar]
  • 221. Rosin DL, Zeng D, Stornetta RL, Norton FR, Riley T, Okusa MD, Guyenet PG, Lynch KR. Immunohistochemical localization of α2a-adrenergic receptors in catecholaminergic and other brainstem neurons in the rat. Neuroscience 56: 139–155, 1993 [DOI] [PubMed] [Google Scholar]
  • 222. Saha S, Batten TFC, Henderson Z. A GABAergic projection from the central nucleus of the amygdala to the nucleus of the solitary tract: a combined anterograde tracing and electron microscopic immunohistochemical study. Neuroscience 99: 613–626, 2000 [DOI] [PubMed] [Google Scholar]
  • 223. Sahuque LL, Kullberg EF, Mcgeehan AJ, Kinder JR, Hicks MP, Blanton MG, Janak PH, Olive MF. Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes. Psychopharmacology (Berl) 186: 122–132, 2006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 224. Sartor DM, Verberne AJM. The sympathoinhibitory effects of systemic cholecystokinin are dependent on neurons in the caudal ventrolateral medulla in the rat. Am J Physiol Regul Integr Comp Physiol 291: R1390–R1398, 2006 [DOI] [PubMed] [Google Scholar]
  • 225. Sawchenko PE. Central connections of the sensory and motor nuclei of the vagus nerve. J Auton Nerv Syst 9: 13–26, 1983 [DOI] [PubMed] [Google Scholar]
  • 226. Sawchenko PE, Arias C, Bittencourt JC. Inhibin B, somatostatin, and enkephalin immunoreactivities coexist in caudal medullary neurons that project to the paraventricular nucleus of the hypothalamus. J Comp Neurol 291: 269–280, 1990 [DOI] [PubMed] [Google Scholar]
  • 227. Sawchenko PE, Benoit R, Brown MR. Somatostatin 28-immunoreactive inputs to the paraventricular and supraoptic nuclei: principal origin from non-aminergic neurons in the nucleus of the solitary tract. J Chem Neuroanat 1: 81–94, 1988 [PubMed] [Google Scholar]
  • 228. Sawchenko PE, Brown ER, Chan RKW, Ericsson A, Li HY, Roland BL, Kovacs KJ. The paraventricular nucleus of the hypothalamus and the functional neuroanatomy of visceromotor responses to stress. Prog Brain Res 107: 201–222, 1996 [DOI] [PubMed] [Google Scholar]
  • 229. Sawchenko PE, Li HY, Ericsson A. Circuits and mechanisms governing hypothalamic responses to stress: a tale of two paradigms. In: Prog Brain Res, edited by Mayer EA, Saper CB. Amsterdam: Elsevier Science, 2000, p. 61–78 [DOI] [PubMed] [Google Scholar]
  • 230. Sawchenko PE, Swanson LW. Central noradrenergic pathways for the integration of hypothalamic neuroendocrine and autonomic responses. Science 214: 685–687, 1981 [DOI] [PubMed] [Google Scholar]
  • 231. Sawchenko PE, Swanson LW. The organization of forebrain afferents to the paraventricular and supraoptic nuclei of the rat. J Comp Neurol 218: 121–144, 1983 [DOI] [PubMed] [Google Scholar]
  • 232. Sawchenko PE, Swanson LW. The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat. Brain Res Rev 4: 275–325, 1982 [DOI] [PubMed] [Google Scholar]
  • 233. Sawchenko PE, Swanson LW, Grzanna R, Howe PRC, Bloom SR, Polak JM. Colocalization of neuropeptide Y immunoreactivity in brainstem catecholaminergic neurons that project to the paraventricular nucleus of the hypothalamus. J Comp Neurol 241: 138–153, 1985 [DOI] [PubMed] [Google Scholar]
  • 234. Schiltz JC, Sawchenko PE. Specificity and generality of the involvement of catecholaminergic afferents in hypothalamic responses to immune insults. J Comp Neurol 502: 455–467, 2007 [DOI] [PubMed] [Google Scholar]
  • 235. Serova LI, Harris HA, Maharjan S, Sabban EL. Modulation of responses to stress by estradiol benzoate and selective estrogen receptor agonists. J Endocrinol 205: 253–262, 2010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 236. Shaham Y, Erb S, Stewart J. Stress-induced relapse to heroin and cocaine seeking in rats: a review. Brain Res Rev 33: 13–33, 2000 [DOI] [PubMed] [Google Scholar]
  • 237. Shaham Y, Highfield D, Delfs J, Leung S, Stewart J. Clonidine blocks stress-induced reinstatement of heroin seeking in rats: an effect independent of locus coeruleus noradrenergic neurons. Eur J Neurosci 12: 292–302, 2000 [DOI] [PubMed] [Google Scholar]
  • 238. Shapiro RE, Miselis RR. The central neural connections of the area postrema of the rat. J Comp Neurol 234: 344–364, 1985 [DOI] [PubMed] [Google Scholar]
  • 239. Shapiro RE, Miselis RR. The central organization of the vagus nerve innervating the stomach of the rat. J Comp Neurol 238: 473–488, 1985 [DOI] [PubMed] [Google Scholar]
  • 240. Shioda S, Nakai Y. Medullary synaptic inputs to thyrotropin-releasing hormone (TRH)-containing neurons in the hypothalamus: an ultrastructural study combining WGA-HRP anterograde tracing with TRH immunocytochemistry. Brain Res 625: 9–15, 1993 [DOI] [PubMed] [Google Scholar]
  • 241. Siever L, Insel T, Uhde T. Noradrenergic challenges in the affective disorders. J Clin Psychopharmacol 1: 193–206, 1981 [DOI] [PubMed] [Google Scholar]
  • 242. Siever LJ, Uhde TW, Silberman EK, Jimerson DC, Aloi JA, Post RM, Murphy DL. The growth hormone response to clonidine as a probe of noradrenergic receptor responsiveness in affective disorder patients and controls. Psychiatr Res 6: 171–183, 1982 [DOI] [PubMed] [Google Scholar]
  • 243. Simonian SX, Delaleu B, Caraty A, Herbison AE. Estrogen receptor expression in brainstem noradrenergic neurons of the sheep. Neuroendocrinology 67: 392–402, 1998 [DOI] [PubMed] [Google Scholar]
  • 244. Smith RJ, Aston-Jones G. Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence. Brain Struct Funct 213: 43–61, 2008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 245. Sofroniew MV, Schrell U. Evidence for a direct projection from oxytocin and vasopressin neurons in the hypothalamic paraventricular nucleus to the medulla oblongata: immunohistochemical visualization of both the horseradish peroxidase transported and the peptide produced by the same neurons. Neurosci Lett 22: 211–217, 1981 [Google Scholar]
  • 246. Spyer KM. The central nervous organization of reflex circulatory control. In: Central Regulation of Autonomic Functions, edited by Loewy AD, Spyer KM. New York: Oxford University Press, 1990, p. 168–188 [Google Scholar]
  • 247. Stone EA, Quartermain D, Lin Y, Lehmann ML. Central α1-adrenergic system in behavioral activity and depression. Biochem Pharmacol 73: 1063–1075, 2007 [DOI] [PubMed] [Google Scholar]
  • 248. Stornetta RL, Sevigny CP, Guyenet PG. Vesicular glutamate transporter DNPI/VGLUT2 mRNA is present in C1 and several other groups of brainstem catecholaminergic neurons. J Comp Neurol 444: 191–206, 2002 [DOI] [PubMed] [Google Scholar]
  • 249. Swanson LW, Petrovich GD. What is the amygdala? Trends Neurosci 21: 323–331, 1998 [DOI] [PubMed] [Google Scholar]
  • 250. Szafarczyk A, Alonso G, Ixart G, Malaval F, Assenmacher I. Diurnal-stimulated and stress-induced ACTH release in rats is mediated by ventral noradrenergic bundle. Am J Physiol Endocrinol Metab 249: E219–E226, 1985 [DOI] [PubMed] [Google Scholar]
  • 251. Taché Y, Garrick T, Raybould H. Central nervous system action of peptides to influence gastrointestinal motor function. Gastroenterology 98: 517–528, 1990 [DOI] [PubMed] [Google Scholar]
  • 252. Terenzi MG, Ingram CD. A combined immunocytochemical and retrograde tracing study of noradrenergic connections between the caudal medulla and bed nucleus of the stria terminalis. Brain Res 672: 289–297, 1995 [DOI] [PubMed] [Google Scholar]
  • 253. Ter Horst GJ, Boer PD, Luiten PGM, Willigen JDV. Ascending projections from the solitary tract nucleus to the hypothalamus. A Phaseolus vulgaris lectin tracing study in the rat. Neuroscience 31: 785–797, 1989 [DOI] [PubMed] [Google Scholar]
  • 254. Ter Horst GJ, Streefland C. Ascending projections of the solitary tract nucleus. In: Nucleus of the Solitary Tract, edited by Barraco IRA. Boca Raton, FL: CRC, 1994, p. 93–103 [Google Scholar]
  • 255. Thayer JF, Lane RD. A model of neurovisceral integration in emotional regulation and dysregulation. J Affect Disord 61: 201–216, 2000 [DOI] [PubMed] [Google Scholar]
  • 256. Thor KB, Helke CJ. Serotonin and substance P colocalization in medullary projections to the nucleus tractus solitarius: dual-colour immunohistochemistry combined with retrograde tracing. J Chem Neuroanat 2: 139–148, 1989 [PubMed] [Google Scholar]
  • 257. Toufexis DJ, Thrivikraman KV, Plotsky PM, Morilak DA, Huang N, Walker CD. Reduced noradrenergic tone to the hypothalamic paraventricular nucleus contributes to the stress hyporesponsiveness of lactation. J Neuroendocrinol 10: 417–427, 1998 [DOI] [PubMed] [Google Scholar]
  • 258. Toufexis DJ, Walker CD. Noradrenergic facilitation of the adrenocorticotropin response to stress is absent during lactation in the rat. Brain Res 737: 71–77, 1996 [DOI] [PubMed] [Google Scholar]
  • 259. Travagli RA, Hermann GE, Browning KN, Rogers RC. Brainstem circuits regulating gastric function. Annu Rev Physiol 68: 279–305, 2006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 260. Tucker DC, Saper CB, Ruggiero DA, Reis DJ. Organization of central adrenergic pathways: I. Relationships of ventrolateral medullary projections to the hypothalamus and spinal cord. J Comp Neurol 259: 591–603, 1987 [DOI] [PubMed] [Google Scholar]
  • 261. Uchida K, Kobayashi D, Das G, Onaka T, Inoue K, Itoi K. Participation of the prolactin-releasing peptide-containing neurones in caudal medulla in conveying haemorrhagic stress-induced signals to the paraventricular nucleus of the hypothalamus. J Neuroendocrinol 22: 33–42, 2010 [DOI] [PubMed] [Google Scholar]
  • 262. Uchoa ET, Sabino HA, Ruginsk SG, Antunes-Rodrigues J, Elias LL. Hypophagia induced by glucocorticoid deficiency is associated with an increased activation of satiety-related responses. J Appl Physiol 106: 596–604, 2009 [DOI] [PubMed] [Google Scholar]
  • 263. Ueta Y, Kannan H, Higuchi T, Negoro H, Yamashita H. CCK-8 excites oxytocin-secreting neurons in the paraventricular nucleus in rats-possible involvement of noradrenergic pathway. Brain Res Bull 32: 453–459, 1993 [DOI] [PubMed] [Google Scholar]
  • 264. Van Bockstaele EJ, Bajic D, Proudfit H, Valentino RJ. Topographic architecture of stress-related pathways targeting the noradrenergic locus coeruleus. Physiol Behav 73: 273–283, 2001 [DOI] [PubMed] [Google Scholar]
  • 265. Van Bockstaele EJ, Peoples J, Telegan P. Efferent projections of the nucleus of the solitary tract to peri-locus coeruleus dendrites in rat brain: evidence for a monosynaptic pathway. J Comp Neurol 412: 410–428, 1999 [DOI] [PubMed] [Google Scholar]
  • 266. Van der Kooy D, Koda LK, McGinty JF, Gerfen CR, Bloom FE. The organization of projections from the cortex, amygdala, and hypothalamus to the nucleus of the solitary tract in rat. J Comp Neurol 1984: 1–24, 1984 [DOI] [PubMed] [Google Scholar]
  • 267. Verbalis JG, Hoffman GE, Sherman TG. Use of immediate early genes as markers of oxytocin and vasopressin neuronal activation. Curr Opin Endocrinol Diab 2: 157–168, 1995 [Google Scholar]
  • 268. Verbalis JG, McHale CM, Gardiner TW, Stricker EM. Oxytocin and vasopressin secretion in response to stimuli producing learned taste aversions in rats. Behav Neurosci 100: 466–475, 1986 [DOI] [PubMed] [Google Scholar]
  • 269. Verbalis JG, Stricker EM, Robinson AG, Hoffman GE. Cholecystokinin activates cFos expression in hypothalamic oxytocin and corticotropin-releasing hormone neurons. J Neuroendocrinol 3: 205–213, 1991 [DOI] [PubMed] [Google Scholar]
  • 270. Walker DL, Davis M. Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear. J Neurosci 17: 9375–9383, 1997 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 271. Walker DL, Toufexis DJ, Davis M. Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety. Eur J Pharmacol 463: 199–216, 2003 [DOI] [PubMed] [Google Scholar]
  • 272. Wang ZJ, Rao ZR, Shi JW. Tyrosein hydroxylase-, neurotensin-, or cholecystokinin-containing neurons in the nucleus tractus solitarii send projection fibers to the nucleus accumbens in the rat. Brain Res 578: 347–350, 1992 [DOI] [PubMed] [Google Scholar]
  • 273. Watanabe T, Nakagawa T, Yamamoto R, Maeda A, Minami M, Satoh M. Involvement of noradrenergic system within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats. Psychopharmacology (Berl) 170: 80–88, 2003 [DOI] [PubMed] [Google Scholar]
  • 274. Watts AG. The impact of physiological stimuli on the expression of corticotropin-releasing hormone (CRH) and other neuropeptide genes. Front Neuroendocrinol 17: 281–326, 1996 [DOI] [PubMed] [Google Scholar]
  • 275. Watts AG. Neuropeptides and the integration of motor responses to dehydration. Annu Rev Neurosci 24: 357–384, 2001 [DOI] [PubMed] [Google Scholar]
  • 276. Weidenfeld J, Itzik A, Feldman S. Effects of glucocorticoids on the adrenocortical axis responses to electrical stimulation of the amygdala and the ventral noradrenergic bundle. Brain Res 754: 187–194, 1997 [DOI] [PubMed] [Google Scholar]
  • 277. Wellman PJ. Norepinephrine and the control of food intake. Nutrition 16: 837–842, 2000 [DOI] [PubMed] [Google Scholar]
  • 278. Wellman PJ, Davies BT. Suppression of feeding induced by phenylephrine microinjections within the paraventricular hypothalamus in rats. Appetite 17: 121–128, 1991 [DOI] [PubMed] [Google Scholar]
  • 279. Williams CL, McGaugh JL. Reversible lesions of the nucleus of the solitary tract attenuate the memory-modulating effects of posttraining epinephrine. Behav Neurosci 107: 955–962, 1993 [PubMed] [Google Scholar]
  • 280. Williams CL, Men D, Clayton EC. The effects of noradrenergic activation of the nucleus tractus solitarius on memory and potentiating norepinephrine release in the amygdala. Behav Neurosci 114: 1131–1144, 2000 [DOI] [PubMed] [Google Scholar]
  • 281. Williams CL, Men D, Clayton EC, Gold PE. Norepinephrine release in the amygdala after systemic injection of epinephrine or escapable footshock: contribution of the nucleus of the solitary tract. Behav Neurosci 112: 1414–1422, 1998 [DOI] [PubMed] [Google Scholar]
  • 282. Willoughby JO, Chapman IM, Kapoor R. Local hypothalamic adrenoceptor activation in rat: α1 inhibits and α2 stimulates growth hormone secretion. Neuroendocrinology 57: 687–692, 1993 [DOI] [PubMed] [Google Scholar]
  • 283. Wittman G. Regulation of hypophysiotropic corticotrophin-releasing hormone- and thyrotrophin-releasing hormone-synthesising neurones by brainstem catecholaminergic neurones. J Neuroendocrinol 20: 952–960, 2008 [DOI] [PubMed] [Google Scholar]
  • 284. Yamada T, Mochiduki A, Sugimoto Y, Suzuki Y, Itoi K, Inoue K. Prolactin-releasing peptide regulates the cardiovascular system via corticotrophin-releasing hormone. J Neuroendocrinol 21: 586–593, 2009 [DOI] [PubMed] [Google Scholar]
  • 285. Yamano M, Bai F, Tohyam M, Shiotani Y. Ultrastructural evidence of direct synaptic contact of catecholamine terminals with oxytocin-containing neurons in the parvocellular portion of the rat hypothalamic paraventricular nucleus. Brain Res 336: 176–179, 1985 [DOI] [PubMed] [Google Scholar]
  • 286. Yamashita H, Kannan H, Ueta Y. Involvement of caudal ventrolateral medulla neurons in mediating visceroreceptive information to the hypothalamic paraventricular nucleus. Prog Brain Res 81: 293–302, 1989 [DOI] [PubMed] [Google Scholar]
  • 287. Yang L, Scott KA, Hyun J, Tamashiro KL, Tray N, Moran TH, Bi S. Role of dorsomedial hypothalamic neuropeptide Y in modulating food intake and energy balance. J Neurosci 29: 179–190, 2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 288. Yang SN, Bunnemann B, Cintra A, Fuxe K. Localization of neuropeptide Y Y1 receptor-like immunoreactivity in catecholaminergic neurons of the rat medulla oblongata. Neuroscience 73: 519–530, 1996 [DOI] [PubMed] [Google Scholar]
  • 289. Young EA, Abelson JL, Cameron OG. Interaction of brain noradrenergic system and the hypothalamic-pituitary-adrenal (HPA) axis in man. Psychoneuroendocrinology 30: 807–814, 2005 [DOI] [PubMed] [Google Scholar]
  • 290. Yu G, Sharp B. Nicotine self-administration diminishes stress-induced norepinephrine secretion but augments adrenergic-responsiveness in the hypothalamic paraventricular nucles and enhances adrenocorticotropic hormone and corticosterone release. J Neurochem 112: 1327–1237, 2010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 291. Zagon A, Rocha I, Ishizuka K, Spyer KM. Vagal modulation of responses elicited by stimulation of the aortic depressor nerve in neurons of the rostral ventrolateral medulla oblongata in the rat. Neuroscience 92: 889–899, 1999 [DOI] [PubMed] [Google Scholar]
  • 292. Zhang JF, Zheng F. The role of paraventricular nucleus of hypothalamus in stress-ulcer formation in rats. Brain Res 761: 203–209, 1997 [DOI] [PubMed] [Google Scholar]
  • 293. Zhao R, Chen H, Sharp BM. Nicotine-induced norepinephrine release in hypothalamic paraventricular nucleus and amygdala is mediated by N-methyl-d-aspartate receptors and nitric oxide in the nucleus tractus solitarius. J Pharmacol Exp 320: 837–844, 2007 [DOI] [PubMed] [Google Scholar]
  • 294. Zheng H, Patterson LM, Berthoud HR. Orexin-A projections to the caudal medulla and orexin-induced c-fos expression, food intake, and autonomic function. J Comp Neurol 485: 127–142, 2005 [DOI] [PubMed] [Google Scholar]
  • 295. Zheng H, Patterson LM, Rhodes CJ, Louis GW, Skibicka KP, Grill HJ, Myers MG, Jr, Berthoud HR. A potential role for hypothalamomedullary POMC projections in leptin-induced suppression of food intake. Am J Physiol Regul Integr Comp Physiol 298: R720–R728, 2010 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Physiology - Regulatory, Integrative and Comparative Physiology are provided here courtesy of American Physiological Society

RESOURCES